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~OR  A 
COUNCIL  DIRECTIVE  ON  THE  CONTAINED  USE 
OF  GENETICl\LLY  MODIFIED  MICROORGANISNS EXPLANATORY  MEMORANDUM 
I.  INTRODUCTION 
1.  In  its Communication  to the Council  "A  Community  Framework  for  the 
Regulation  of  Biotechnology"  (Com(86)573  final>,  the  Commission 
signaled  its intention to introduce proposals  for  Community Regulation 
of  biotechnology which  would  address  two distinct aspects of  the use 
of  genetic engineering: 
A.  Levels  of  physical  and  biological  containment,  accident  control 
and waste management  in industrial applications; 
B.  Authorization  of  planned  release 
organisms  to the  environment. 
of  genetically  modified 
2.  The  detailed rules  for  the  containment  of  genetically  modified 
microorganisms  which  are  pathogenic  to  humans  are  laid down  in the 
proposal  for  a  Council  Directive on  the protection of  workers  from  the 
risks  related to  exposure  to  biological agents at work.  These  rules 
have  worker  protection  as  their  primary  objective  and  are 
complementary  to  the  proposals  on  contained  use  of  genetically 
modified microorganisms  accompanying  this  memorandum. 
3.  A  further proposal  deals  with  the release  of  genetically modified 
organisms  to the  environment,  and  together with  this  proposal  and  the 
worker  protection  proposal  forms  a  coherent  legal  framework  to deal 
with questions  of  genetically modified  organisms. 
4.  It  is  obviously  necessary that installations  carrying  out  work  with 
genetically  modified  microorganisms  do  this  in  a  manner  wl1ich  presents 
o~- minimizes  any  pot.cntiu.l  risk  to  man  and  the  cmvironment  and  while 
it  is  recognized  tha·t  _in  the majority of  cases  the microorganisms  used 
will  constitute a  minimal  risk  and  require  only that good  operating 
practices  are  respected,  there will  be  other  cases  where  by virtue of 
the  presumed  pathogenicity or other properties  of  the  microorganism in 
question,  special  measures  for containment and,  if necessary,  accident 
response  procedures  will  be  appropriate.  Therefore,  regulatory 
measures  are  needed  to  ensure  that  the  use  of  genetically  modific:~d 
microor']c.ni~3ms  is  und(2rtnkcn  \·Jith  the  c1.~9ree  of  security  (contrul l 
commensuri'ite  with  the  potential risk  involved. 
5.  In  1986,  the  OECD  Council  issued  a  Recommendation  on  safety 
considerations  for  applications  of  Recombinant  DNA.  The  Commission 
and  the  Member  States  participated  in  the  preparation  of  this 
Recommend  a t:.ion. 
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The  ·technical control 
OECD  Reconunendation. 
o:f'ihe Commission's  prbp9sals  are based  on  this 
6.  As  · the devel9pment  and  industr'ial  applic~tion of the "new· techniques 
of  genetic-engineering  continue to  expand  vef:y  rapidly the  Commission 
considers:  . that,  both  from  the viewpoint of  iwoiding the "fragmentation 
of  . the market , and· of  ensuring  a  high  and  ,consistent" standard  of 
prote~tion  ·for man  and  the  en~ironm~nt,  regut~tory m~asures  sho~ld be 
introduced  at a  Community  level ., 'iri  relation''. to the" contained  use  of 
gen~tically modified microorganisms. '  )". 
.  ~  ··.  ~· 
II."' .THE  CONTfiiNED  USE  OF  GENETICALLY  MODIFIED  MICROC:mGAiUSMS 
1.  LEGISLATION  IN  THE  MEMBER  STATES  OF  THE  EUROPEAN  COMMUNITIES 
Several  Member  States  have  been 
some  have  issued  specific  rules 
biotechnology. 
reviewing existing  regulations 
concerning  the  c6ntained  use 
and 
of 
In  Belgium  a  'rONA Advisory  Committee'  is  in creation,  in order to 
channel  biotechnology-related issues  to  the  competent  authorities. 
There  is  no  specific regulation  in the field of  biotechnology but it 
is  estimated that  a  number  of  existing  rules would  apply.  These 
include  systems  of  authorizations  for  production,  and  for  liquid and 
solid  waste  transport  and  disposal  as well  as  legislation on  worker 
protection. 
In  Denmark  the  Folketing adopted  in May  1986  a  bill on  'Environment 
and  Gene  ~echnology'.  Concerning  workers'  safety  an  order on  "Gene 
Technology  and Working  Environment"  was  issued  in  September  1987. 
Research  can  be  carried out  only in  laboratories  classified  for  the 
purpose  by  the  National  Labour  Inspection,  and  each  experiment  has  to 
be  notified and  registered.  Production in industry must  be  previously 
licenced  by the  competent  authorities.  This  involves  the review of  a 
risk  assessment  study  and  the  approval  of  the  containment  and 
emergency measures  proposed  by the  applicant. 
In  _the  Federal  Republic  of  Germany  the  contained  use  of  genetically 
modified  m:i.droorganisms  is  subject  t.o  several provisions.  Research 
activities  are  subject  to  guidelines;  the  disposal  of  liquid wastes 
from  production  and  utilization of  genetically modified  microorganisms 
are  subject to  authorization,  as  is  the establishment  and  functioning 
of  industrial installations  producing  medicinal  products  or  their 
intermediates  using  biotechnology. 
Moreover  the  Association  CBerufsgenossenschaft>  of  the  chemical 
industry  has  prepared  a  recommendation  for  accident  prevention  in 
laboratories  and  industrial  installations  using  biotechnologies.  The 
Minister  for  Social  Affairs  has  given  his  agreement  and  the different 
as sociu tions  will  no\v  implement  these  .recommendations  in  their  m,Tn 
.sect~ol~ . 
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In  France  there  are guidelines  ~qr  resea~8h with genetic technologies 
which  provides  for  voluntary  notification  of  r:ertain  hi.crh  risk 
projects  to  a  scientific  cmlll"ii ttee  (Com.misEion  de  Classement). 
Industrial  activities u3i;1q  genet.ic<:tlly modified  microorganisms  are 
subject  to the  Law  on  'Classifi~d  Installations  for  Environmental 
Protection'  and at  present  ~u3t  :be  authorized  before  beginning  to 
work.  An  interdepartmental  work{ng  group,  meeting  by initiative of 
the  Prime Minister,  is evaluating ~hether industrial activities  should 
be  distinguished  on  the basis cf :the microorganism used  and  submitted 
to declaration when  usir.g  low risk .microorganisms. 
I 
Greece  has  set  up  an  inter.dJpartn1ental  Committee  1  the  'Ad-Hoc 
Committee  on  Biohazards'  which  is responsible  for the  coordination of 
biosafety activities in relation  t~ research projects. 
In  Ireland  a  statutory Recombinant  DNA  Committee  has  been  set up  to 
re.ceive  and  examine  notifications jfor research projects falling within 
categories  of  high  risk.  The  Committee  also receives  proposals  for 
industrial  large scale work  and  is!sues  case by  case  recommendations  to 
the  local authorities  on  conditions  to be  met  regarding the plant's 
design,  the  containment measures  an,d  the safety of workers. 
I 
In  Italy,  Spain  and  Portugal  no  ~pecific guidelines or rules 
the  contained use  of  biotechnolog:y;  however,  a  number  of 
regulations  related  to products  ar~ applicable. 
apply to 
existing 
In  Luxernbouro  there  are  no  specific  laws  with  respect  to 
biotechnology.  At  present,  both  laboratories  and  industrial 
installations  using  genetic  technologies  fall  under  the general  rules 
for  'Classified Installations'  where  authorization  is needed  before 
beginning  to work. 
In  the  Netherland~  guidelines  have  been  set  up  for  research  and 
industrial  production.  Also,  genetically  manipulated  microorganisms 
are  regulated under  the  Nuisance  Act  which  requires  a  licence  for 
hazardous  installations.  The  licence could  specify the provisions  to 
be  adopted  for  containment  and  emergency  response.  The  licence is 
given  by  thE~  Community  Council  and  is normally  based  on  advice  of  the 
Recombinant  DNA  Committee. 
In  t.he_ll.ni_ted'  KinQ.d~ml the  general  requirernent.s  of  t:he  Health  and 
S~fety  at  Work  Act  ~11d  the  Genetic  Manipulation Regulations,  issued 
11nder  this  Act,  apply to  researchers  and  industries  using  genetic 
technologies.  Notification  of activities is required,  and  Guidelines 
on  Safe  Work  arE)  issued  by  the  Advisory  C01runittee  on  Genetic 
Manipulation,  while  the  Health  and  Safety Executive  inspectors  carry 
out  active controls  for  enforcement.  1'he  Health  and  Safety Commission 
is  planning  to  propose statutory notification for  the  large scale use 
and  planned  release of  genetically modified  microorganisms,  because at 
present  Stich  notifications are  on  a  voluntary basis. ---:-:  - 4  -
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2~  COMMENTS  ON  THIS  PROPOSAL-FOR  A DIRECTIVE_ 
A.  General  . 
This  proposal deals  with  the  contained use  of genetically  modified 
microo"rganisms  including questions  of  waste  and  accident prevention. 
While  some  naturally  occurring microorganisms  may alsp be  of  concern 
in  that they may  present dangers  to plants,  animals  or the  environmerit 
i~  general,  the  Commission  considers  that  in  the  first  instance 
priority  should be  given to a  legal  framework  which will both provide 
adequate  protection and at the  s~me time allow society to benefit  from 
this rapidly evolving technology. 
The  Comn1ission  is  however  working  towards  the  development  of  coherent 
methods  of  risk  assessment  iri  this field  and  will  on  this  -basis 
examine  if and  how  the  accompanying proposal  could  be  modified  or 
extended to  cover non-genetically modified microorganisms. 
Genetically  modified microorganisms  can be  released to the environment 
in the  course of  their contained use  in two  different ways: 
- routine  release  in  normal  operating  conditions e.g.  as  wastes  or 
in airborne emissions, 
accidental  release  in  abnormal  operating  conditions  i.e. 
which  significant  release in  the environment  following  an 
causes  the activity to get out of  control. 
event 
Iri  certain cases  such releases will  pose risks to  human  health and  the 
environment;  it is therefore necessary to: 
1)  Identify these cases, 
2)  Adopt  working  practices  and  containment  measures  corresponding 
to the  hazard  the microorganism represents, 
3)  Prevent  the  accidental  release  of  hazardous  microorganisms  and 
lirnit the  consequences  of  any  such accident  which  may  occur. 
This  proposal  for  a  directive covers  the  steps  from  1  to  3. 
For  thr2  purp.ose  of  this directive genetically modified microorganisms 
are divided  i~ two  groups: 
Inicrool_'<;:Janisms  presenting  a  minimal  hazard  (Group  I)  t.o  which 
relatively  simple  rules  of  good  hygiene  and  safety practice shall be 
applied,  and  other  microor~anisms  (Group  II)  where  containment,  waste 
control  and  in  some  cases  emergency  response  procedures  are essential. 
In  all cases  users  have  to declare  the  fact  that they are carrying out 
operations  involving genetically  manipulated  microorganisms  to  the 
responsible authorities  and  carry out  a  hazard  assessment. 
A  system  of  notification  to  the  competent  authority 
established,  to  allow  effective  monitoring  and  control 
correctness  of  the_  classification and  of  the  containment 
applied. 
is  then 
of  the 
measures 
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~he  time  schedule  and  the  content of  the notification  is dependent 
upon  the classification  of  the  microorganism and  on  the  scale  of  the 
operation  involved.  In respect of  the latter the  Commission  considers 
more  appropriate to  adopt  a  flexible approach  and  distinguish  the 
activities  on  the  basis  of  their  purpose.  'Industrial  scale 
operations'  would  include  manufacturing processes,  and  pilot  plants 
whereas  'non-industrial  scale  operations'  would  include  teaching, 
research and  development activities. 
In  order to  ensure that  the probability  of  accidental  release  is 
reduced  to  a  minimum,  the  proposal  envisages  special provisions  in 
such  cases  of  higher risk  or incertitude.  These  are represented by 
the  industrial scale  operations  using  microorganisms  belonging  to 
group  II.  The  notification in this  case will  be more  detailed and  the 
user  will  prove  that  he  has  studied possible  causes  of  accid~nts, 
anticipating  the  combination  of  events  which  might  lead  to  an 
unintended  release and  adopted safety measures  and  emergency response 
plans  where  appropriate.  The  user must  also  forward  to the  competent 
authority  the  information  necessary to  set up  an  emergency plan  for 
the area  surrounding  the installation,  should  an  accident  occur. 
',  '·  ..  . , 
In  addition,  the 
authorities  to be 
territory  and  for 
set up at Community 
proposal  for 
notified of 
an  effective 
level. 
a  Directive provides  for  the  competent 
accidental releases  occurring in their 
preventive and monitoring  system to be 
General  provisions  are  made  for  the adapting  of  the  directive  to 
technical  progress. 
'l'echnical  annexes  laying  down  containement  and  waste  measures  are 
largely drawn  from. the  OECD  Reconunendation. 
B.  Particular 
JllJ.-:.e ct  ivE.l 
ARTICLE  1 
comments  on  certain  articles  of  the  pro:oos..e.d 
"the  definitibn of  'microorganism'  is  intended to  cover  microscopic 
living  entit~es, cellular  or  non  cellular,  with  capacity  of  self 
perp~tuation.  Microorganisms  can  be  viruses,  prokaryotes  (for 
.ex~~ple,  bacteiial  eucaryotes  <for  example,  fungi)  or  proti~ta.  This 
. definition  includes  mammalian  and  plant cell cultures . 
.  "  .  .  ',  ..... '  "-,......,  .:  .,  ~.  . 
·~  '  ,  .  .,  ~  "'  :0.,  t  . 
.. ''l'he  'cl0finition  of- 'genetically modified microorganism'  is intended  to 
l~e  broad ,,so  ...  as., t:o  include  present and  future  techniques..  It excludes 
.,d,eletion,  · mutagene.sis,  conjugation,  trans-formation,  transduction  or 
any  oth~r process  if they  are  carried  under  normal  physiological 
·:·  conditions  and  do  n9t  involve  ·the  use  of  recombinant  DNA  techniques  or 
~:vmetical.ly modified  organisms. 
:<~, 
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The  definition of  contained use  relies upon  the degree  to which  both 
physical  and biological  methods  are  used  to  control  or  restrict 
dissemination  of  microorganisms.  For  this  purpose  'biological 
barriers'are  those  characteristics  the microorganisms  possess  .which 
limit  their ability  to survive.  'Physical  and  chemical  bari\iers' 
consist  of  a  set of  equipment,  operating procedures  and  practices  and 
facility  design which restrict dissemination of  the microorganism into 
the  unrestricted environment.  This  approach is  purposely flexible: 
there  are  a  large  number  of  combinations  of biological,  physical  and 
chemical  barriers that  could  be  deployed to  prevent  release into the 
environment. 
ARTICLE  2,  ARTICLE  4  AND  ARTICLE  5 
These  articles  represent  the  general  provision  of  the  proposed 
Directive.  Article  2  sets out the criteria for  the classification of 
genetically  manipulated microorganisms,  Article  4  the obligation  to 
carry  out  a  prior safety  assessment of  the operation and to keep it 
under  review,  Article  5  establishes  the  containment  measures  to  be 
applied  for  each  group  of  microorganism. 
ARTICLE  6· 
This  article provides  for  an  initial declaration  to  be  forwarded  by 
all  persons  wishing  to work  with genetically modified microorganisms. 
Each  declaration will  refer to  a  particular installation or building. 
A  60  day waiting period is established in order to allow the  competent 
authority  receiving  the  declaration to carry out effective inspection 
of  the installation  concerned  and  enforce the specific duties  placed 
on  the  users  under  this  proposed  Directive.  This  declaration, 
requiring  a  minimum  set of  particulars  (listed  in  Annex  IV  A)  \'lill 
enable  the  competent  authority to  know at  least where  the  contained 
uses  are being undertaken. 
ARTICLE  7 
This  article establishes  the  requirements  for  users  of  microorganisms 
from  Group  I  'according  to  the  scale of  use: 
- non-industrfal  scale operations:  record  of  work  must  be  ava~lable 
upon  request  of  the  competent  authority~ 
- industrial  scale operations:  prior notification of  tl1e  information 
listed in  Annex  IV.B,  work  can  proceed  immediately. 
l\R'T'ICLE  8 
This  Article establishes  the  requirements  for  users  of  microorganisms 
from  Group  II according  to  the  scale of  use: 
non-industrial  scale  operations:  prior  notification  of  the 
information  listed in  Annex  IV .C  \vith  a  15  days  waiting  period; 
- ir1dustrial  scale operations:  prior notification of  the  information 
listed in  Annex  IV.D  with  a  60  days  waiting  period. 
,  ..  .  _ ..  , 
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ARTICLE  9 
This  article establishes  the  requirements  for the  updating  of  the 
notification  where  the  users  shall  inform the  competent authority as 
soon  as  possible  of all  information  or  modifications  which  could 
affect  the notification  already made.  This  would  include  a  change  in 
the  microorganism or  in the  techniques  used  or  in  the  number  of 
personnel  involved  in  the  operation,  thus  enabling  the  competent 
authority to  be  informed of all ending activities. 
ARTICLE  10  and  ARTICLE  11 
These  artitles  specify  the  responsibilities  of  the  competent 
authorJ.ties  ~ho shall  receive the declarations  and  the notifications. 
In  particular  they  will  examine  the  notification,  carry  out 
inspections  and  checks,  and  take all requisite measures  with  a  vi~w of 
preventing  accidents  or  limit the  consequences  of  such  accidents, 
including drawing  up  of external  emergency plans. 
ARTICLE  12 
This  article concerns  the  information which  the users  must  give  to the 
competent  authority in  the  event  of  an  accident and  the  consequent 
action that shall be  taken  by  the latter. 
ARTICLE  13 
This  article specifies  the  information which  the Hember  States  are to 
send  to  the  Commission:  extracts  from  the  notifications  concerning 
industrial  scale  operations  with  Group  II  microorganism  and 
information  about  accidents  occurring.  This  article also provides  for 
the  organization of  exchange  of  information  and  the  setting up  of  a 
data  base  to which  the  Member  States  are  to  have  access. 
ANNEX  I  and  ANNEX  II 
These  annexes  provide  the  c.riteria  whch  must  be  folloVTed  in 
classifying  a  genetically  manipulated  microorganism  and  in  assessing 
the  risks  for  human  health  and  the  environment  which  may  be  entailed 
by  .i.U;  contained  use.  Both  these  ann  .. ~xes are  based  on  the principles 
outlinc~d  .i.n  the  OECD  Heport  cited in  I. 5. 
Tn  bot.h  the:3c~  iHmexc:),  unless  it 
definition  of  pathogen  applying is 
OECD  report i.e.: 
.i.s 
the 
differently  specified,  the 
same  as  that outlined  in the 
Pathogenicity  is the potential ability of  living organisms  and  viruses 
to  cause disease  in  man,  animals  an  plants. 
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PROPOSAL 
FOR  A 
COUNCIL  DIRECTIVE  ON  THE  CONTAINED  USE 
QF  GENETICALLY  MODIFIED  MICROORGANIS1·1S. 
THE  COUNCIL  OF  THE  EUROPEAN  COMMUNITIES, 
Having  ·  regard  to  the  Treuty  establishing  the  Europeun  Economic 
Community  and  in particular Article  10 0  A  thero_f, 
Having  regard to  the  proposal  of  the  Commission  (1), 
Having  regard  to  the  opinion  of  the  European  P~rliament  (2), 
i-Iaving  regard  to  the  opinion  of  the  Economic  and  Social  Comrni t tee  ( 3), 
Whereas  disparity between  the regulation  of  the  contained  use  of 
genetically  modified  microorganisms  which  are  in  effect  or  in 
preparation  in the  Member  States  may  create  unequal  conditions  of 
competition,  whereas  these  distortive  effects  are  specifically 
important  in  areas  where  technical  progress  of  the  undertakings 
involved  largely depend  on  the  conditions  under  which  the dperation 
concerned  may  legally  be  carried  out,  whereas  disparities of  these 
conditions  in the  Member  States  thus directly affect the  functioning 
of  the  internal market; 
Whereas  measures  for  the  approximation of  the provisions  of  the  Member 
States  which  have  as  their object the  establishment  and  functioning of 
the  internal market  shall,  inasmuch  as  they  concern  health,  safety, 
environmental  and  consumer  protection,  take  a  high  level  of  protection 
as  a  base  and  provide,  despite existing differencies  in  economies  of 
the  Member  States,  for  cqunl  standard  of  protection  throughout  ths 
Commur:.i t.y; 
HhercciS  under  the  'l'rcoil ty,  act.ion  by  the  Community  relating 
environment  shall  be  basecl  on  the  principle  that preventive 
shall  be  taken; 
to  the 
ac:tion 
\·lh e rec.  s  l·.J'.r;_· 
( 4)  of  t~ltr~ 
evalue.tion 
en  vi  ron1~1c: n t 
concen  t  ~·u h::; 
Fourth  En·:ironmcntal  1\cti.un  Progran~:-ne  of  19  0-::::t-.ob?.r  19:.:7 
Europ,~an Communities  dec:lares  that measures  conce1:ning  •,:i:e 
and  best:  u~;e  of  biott;chnology  .,.,,ith  n~qard  to  tile:: 
are  a  priorit:y  a.n:::i1  whore  Communit~y  <Jction  sh0nJd 
Hhereas  the?  development  of  biol:echnology  is  such  as  to  c:onU:ibute  to 
the  economic:  expahsion  of  the  Member  States;  whereas  this  impJ.ies  th~t 
genet  i cu lly  1nod -t f i ed  Ini  cJ:()o:r·'-J ani  sn1s  \·.rill  l)C  us  Gd  i 11  indus  tJ_~ i.c1l  and 
non--indusLci,Jl  scale operations; 
\·-lh::.!r:-·~::·.:~~  r1  L:·~:.c-:····:1rgar1.i.S!t1.~,  \·.r}~t(~tll~::r  .rt~_1_t-;tlSL~d  5_n  t!~-2  cn\rir·(Jnr~i·?~Jt  cts  r:.~  ~: 
O.ln_i.;"s.i-~';1,  Liquid  or  S•.)JiJ  ·,·:a:;les  or  by  acci_denl:  in  ~he  c·~-'li:_-,,e  of  tlh:::i;: 
contairwd  use  may  repl·oduce  and  spread  crossing  national  frontiers 
thereby affecting bordering  11ember  States or the  Community  as  a  vlhole; 
(1) 
{7) 
(  :.~  ) 
( .j) 
;l  .. 
.,_,  •  1...•  • 
,-.  --~  I  ;."::-
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Whereas  the contained  use 
be  carried out in  such way 
the  health of  the  general 
attention to the  prevention 
of genetically modified microorganisms  must 
as  to limit their negative  consequences  for 
population and  the  environment giving due 
of accidents  and  the control  of wastes; 
Whereas  it is  therefore necessary  to approximate  legislation in the 
Member  States establishing  a  common  procedure  for  the evaluation of 
the  potential risks  arising in  the  course  of  the  contained  use  of 
genetically  modified  microorganisms  in  research,  development, 
manufacture,  storage,  transport,  waste  treatment  and disposal  in order 
to  enable  the  safe  development  of  biotechnology  throughout  the 
Community; 
Whe~cas  the  precise  nature  and  scale  of  risks  associated  with 
ge~etically  modified microorganisms  are conjectual  and  the  hazards 
involved  must  be  assessed case  by  case,  whereas  particular attention 
must  be  given  to  operations  using  certain  genetically  modified 
microorganisms; 
Whereas  genetically modified  microorganisms  must  be  classified  in 
relation  to their  hazard,  whereas  in the  absence,  at the moment,  of 
specifications  necessary for  allocation of  these  classes  it  seems 
appropriate  to  provide  criteria  for  classification,  whereas  to 
evaluate  hazard  for  human  health  and  the  environment it is necessary 
to enumerate  certain characteristics of  the  assessment; 
Whereas  the possible  accidents  should 
integration  of  containment  measures 
development,  construction and  operation; 
be  obviated 
at  the 
at source  by the 
various  stages  of 
Member  State is necessary in 
of  the  contained  use  of 
trace the  origin  of  any 
Whereas  a  permanent  inventory within  each 
order  to  follow  closely the  development 
genetically  modified microorganisms  and  to 
deleterious effect that might arise; 
Whereas  any  person,  before  undertaking  for  the  first  time  the 
contained  use  of  a  genetically modified  microorganism  must  forward  to 
the~  compet:.ent  authority a  declaration  of  intent allowing  the  author:i ty 
to  ensure  that  the  proposed  activity does  not  present  a  danger  to man 
and  the  environment; 
Whereas,  in  the  case  of  industrial  operations  involving  certai.n 
genetically  modified  microorganisms  it is  necessary  for  the  user to 
provide  the  competent  authorities with  information  including details 
of  the microorganism  used,  the  installation  and  the  operation  in 
~uestion,  with  a  view  to  reducing  the  hazards  of  accidental  release 
and  enabling  the  necessary  steps  to  be  taken  to  reduce  their 
consequences; 
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Whereas  it is  necessary to  lay down  that  any  person  outside  the 
installation  liable  to  be  affected  by  an  accident  should  be 
appropriately  and  effectively  informed  on  all ·matters  relating  to 
safety,  whereas  area  and  persons  liable to be  affected are defined  by 
the  emergency plans  of  the industrial operation;  whereas,  in order to 
mitigate  the  consequences  of  an accidental  release the  information  on 
.potential  hazards  and  measures  to  be  taken  has  to  be  communicated  on 
an  active basis to the  concerned  persons without  a  request being made, 
though  some  kind  of  public  information media,  such  as  leaflets  of 
information boards; 
Whereas,  if an  accident occurs,  the  user must  immediately inform the 
competent  authority and  communicate  the  information  necessary  for 
assessing  the· impact  of  that accident; 
,. 
Whereas  a  continual analysis  of  the situation throughout  the  Community 
must  be  undertaken  in order to promote  both the establishment of lists 
of  activities which  ought to be  subject to  special safety measures  or 
tHe  imposition of  more  stringent  containment  measures,  whereas  in 
order  to  enable.  this analysis  the Member States should  forward  to the 
Commission  information regarding  certain industrial  scale operations 
with  genetically modified  microorganisms  ~nd  the accidental releases 
ociccurring  in their territory, 
HAS  ADOPTED  THIS  DIRECTIVE: 
ARTICLE  1 
1.  For the  purposes  of  this  Directive: 
(a)  "Microorganism''  means  any microbiological entity,  cellular or non-
cellular,  capable  of  replication. 
Cb)  "Genetically  modified  organism"  means  any  organism derived  from 
the  formation  of  a  new  combination  of  genetic  material  by  the 
insertion  of' nucleic  acid  molecules  produced  by whatever  means  outside 
the  cell,  into  any virus,  bacterial  plas1nid  or other vector  system  so 
as  to  allow  their  i.ncorporation into  a  host  organism  i.n  which  they do 
not  naturally occur  but  in  which  they  arc  capable  of  contjnuod 
pt:opaqat.ion. 
C  c)  "1\  contained  use"  is  any  operation in  which  microorganisms  are 
genetically  modified,  cultured,  stored,  transported,  destroyed  or 
disposed  of  and  for  which  physical,  chemical  or biological barriers 
are  used  to  limit  their  contact with  people  and  the  environment.  It 
does  not  include  operations  with microorganisms  to  be  released  in the 
'~lJV.i.ronm(~nt~  unde:c  Council  D.i.n:ctiv•.:  (clc·Jiberate  r~J.easc)  o": 
products  to  be  placed  011  the  market  under  relevant  EC  legislation. 
(d)  "Industrial  scale operation"  is any  contained use  carried out as 
part  of  a  manufacturing process,  incl~ding uses  at the  pilot plant 
stage  for  the development  of  such processes. 
(e)  "Non-indus trial  scale  oper;;: tion"  .!. s  any  o t.h2r  contained  use 
.i.nc l ucling  for  teaching,  research  and  clevelopmen t  pul.-poses. - 11  -
(f)  "Accident"  means:  any  incident  involving  significant  and 
unintended  emission  of  genetically  modified  microorganism  in  the 
course  of  their  contained  use  that  leads  to  a  serious  danger, 
immediate  or delayed,  to  the  health of the general  population or the 
environment. 
(g)  "User"  means:  any  natural or  legal person  responsible  for  the 
contained use  of genetically modified microorganisms. 
<h>  "Notification"  means:  the presentation of  documents  containing the 
requisite information  to the  competent authority of  a  Member  State. 
ARTICLE  2 
1.  For  the  purpose  of  this  Directive, 
microorganisms are classifed as  follows: 
genetically  modified 
Group  I:  Those satisfying the criteria of  Annex  I 
Group II: Those other than Group  I 
2.  For  non-industrial  scale operations,  the classification by the user 
of  particular  microorganisms  may  be  provisional.  In  this  case 
microorganisms  will  be  referred to  as  'equivalent'  to  the  above 
groups. 
ARTICLE __3. 
1.  This  Directive shall  apply without  prejudice to the provisions  of 
Council  Directive  . . .  on  the  protection of  workers  from  the  risks 
related to exposure  to biological agents  at work. 
2.  Articles  5  to  10  do  not  apply  to  the  transport  of  genetically 
modified  microorganisms  on  public roads,  rail,  inland waterway,  sea  or 
by air. 
1.  'I'he  Hembe.r  St<ltes  shall  take  the  necessary steps  to  ensure that the 
contained  use  of  genetically modified  microorganisms  shall  be  carried 
out  in  such  a  way  as  to  prevent their neg<ltive  consequences  for  the 
health bf the  general.  population  and  the  environment. 
2.  To  this  end,  the  user  shall carry  out  a 
contained  uses  in  respect of  the biological 
incur. 
prior assessment  of  the 
hazards  that  they  may 
3.  In  ~akin~ such  an  assessment  the  user  shall,  in particular,  take 
due  accoun·t  of  the  relevant  parameters  set  out  in  Annex  II  for  any 
C]C:neLically  modif.i.Gcl  microorg<lnism  he~  is  propos_i_nCJ  to  use. 
4.  A  record  of  the  safety  assessment  shall  be  kept  by  the  user  and 
made  available to the  competent authority upon  request. 
- -~ 
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ARTICLE  5  ,, 
_t;' 
1.  For  microorganisms  in 
Microbiological  Practice as 
shall be  applied. 
Group  I  ~he  princ~ples  of  Good 
laid out  in C:ouncil  Directive  80/1107/EEC 
2.  In  addition to  these principles,  th~ containment  measures  set out 
in  Annex  I I I  shall  be  applied,  as  app:;:-opriate,  to contained _uses  of 
microorganisms  in Group  II  so  as  to  ensur~ a  high  level of  safety. 
3.  The  containment measures  applied  shall be  periodically reviewed  to 
take  into  account  new  scientific or technical  knowledge  relative to 
risk  managem~nt and  waste disposal. 
ARTICLE  6 
Any  person wishing  to undertake  for the  first time  in a  particular 
installation  the  contained  use  of genetically modified microorganisms 
shall  be  required  to  submit  to the  competent authority,  at least  60 
days  before  commencing  such  use,  a  declaration containing at least the 
information listed in Annex  IV.A. 
ARTICLE  7 
1.  Users  of  microorganisms  classified in,  or equivalent to,  Group  I  in 
non-industrial  scale operations  shall be  required to keep  records  of 
the  work  carried  6ut  which  shall  be  available  to  the  competent 
authority on  request. 
2.  Users  of microorganisms  classified in  Group  I  in industrial scale 
operations  shall be  required to  submit  to  the  competent  authority, 
before  commencing  such  use,  a  notification cont.aining  the  information 
listed  in Annex  IV.B.  The  information shall  be  sufficient to  enable 
the  competent  authority  to  assess  the  correctness  of  the 
classification.  After  submission of  the notification the industrial 
scale operation can  proceed. 
1.  Users  of  :microorganisms  classified in or equivalent  to  Group  II in 
ncm-- induf;trial'  scale operations  shall  be  required  to  submit  to  the 
competent  authority,  before  commencing  such  use,  a  notification 
containing  the  in  formation  listed in  Annex  IV. C.  'rhe  contained  u st=: 
may,  in absence  of  any  indication to  the  contrary  from  the  competent 
authority,  proceed  15  days  after submission  of  t:he  notification. 
2.  TJsers  of  microorganisms  classified in  Group  II in  industrial  scale 
operations  shall  be  required  to  submit  to  the  competent  authority 
before  colllmencing  such  use,  a  notification containing: 
Infonnation  aboul:  t:he  microorganism( s), 
Information  about  personnel, 
Information about  the installation, 
Information about waste management, 
Information about  accident prevention and  emergency response plans, 
The  safety assessment  referred to  in Article  4, 
the  details  of  \dlich  are  listed in  Annex  IV .D. - 13  -
The  contained use  may,  in  absence  of  any indication to the contrary 
from  the  competent  authority,  proceed  60  days  after submission of  the 
notification  or  earlier,  with  the  agreement  of  the  competent 
authority. 
ARTICLE  9 
The  competent authority  shall be  informed  as  soon  as  possible and  the 
declaration  and  the  notification under  Articles  6,  7  and  8  shall be 
modified,  when  the  user becomes  aware  of  new  information or modifies 
the  contained  use  in  a  way  that  could  have  significant consequences 
for  the  risl~ posed  by the contained use,  or which  affects  the  contents 
of  the original declaration and  notification. 
ARTICLE  10 
1.  Member  States  shall  designate  the  competent  authority  or 
authorities  who  shall  ensure that this Directive is correctly applied 
and  shall receive  the declaration and  the notifications referred to  in 
Articles  6,  7  and  8. 
2.  The  competent  authority  shall  examine  the  conformity  of  the 
declaration  and  the  notification  with  the  requirements  of  this 
Directive,  the  accuracy and  completeness  of  the  information given  and, 
where  appropriate,  the  adequacy of  the waste management,  safety,  and 
emergency  response measures. 
3.  If  necessary,  the  competent authority  may  ask  the user to provide 
further  information or to  introduce modifications  to the  conditions  of 
the  proposed  contained use. 
4.  In  this  case  the  relevant  waiting period  is extended  until  the 
notifier  complies  with  the  request of  the  competent  authority and  has 
informed  them  thereof. 
ARTICLE  11 
The  competent, authority is also  responsible  for: 
- organi.zing  1nspections  and  other control  measures  to  ensure  the 
user's  compliance with  this  Directive, 
-- Ensurin9  that ,whe1:e  necessary,  before  an  operation  commences  an 
emergency  plan  is  drc:lwn  up  to deal  \vit.h  biological  hazards  outside  the 
installation  in  the  event  of  an  accident  and  that  the  emergency 
services  are  aware  of  the  ha~ards and  are  informed  of  such  in writing, 
- Ensuring  that all  persons  liable  to  be  affected  by  an  accident are 
.Lnformecl  in  an  appropriate  manner  of  the  emergency  response  measures 
and  of  the  correct  b1c:hoviour  to  adopt,  sending  to  the  other  Nembe::: 
S ta  tE:s  concerned  the  same  information  as  that  which  is disseminated  to 
their  own  nationals.  The  information  shall  be  commJnunicated  to  the 
above  mentioned  persons  without  their  request  and  shall  also  be 
published. 
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ARTICLE  12 
1.  Member  States shall  take the necessary measures  to ensure that, if 
an  accident occurs  which  can  endanger  the  health  of  the  general 
population  and  the  environment,  the  user  shall  be  required  to 
immediately  inform the  competent authority specified in Article  10  and 
provide the  following  information: 
the  circumstances  of  the accident, 
the identity and quantities of  the microorganism(s)  released 
any  information necessary  for  the  assessment  of  the effects of  the 
accident  on  the  health  of  the  gsrieral  population  and  the 
environment, · 
the  emergency measures  taken. 
2.  The  Member  States shall: 
ensure  that any  emergency,  medium  and  long-term measures which  may 
prove  necessary are  taken,  and  immediately alert  any  Member  State 
which  could  be affected by the accident, 
collect,  where  possible,  the  information  necessary  for  a  full 
analysis  of  the  accident and  make  recommendations  for  the avoidance 
and  the  limitation of  the  effects of  similar accidents  in the  future . 
.8.RTICLE  13 
1.  Member  States shall: 
a)  ensure that in the  case  of  contained uses  notified under Article 
8. 2,  the competent  authority sends  the  follov;ring  information to the 
Commission  within  60  days  of  receipt of  the notification: 
- the  identity,  proposed  uses  and  potential risks  of  the 
microorganism(s), 
- a  summary  of  the  containment measures  applied, 
- a  summary  of  t~he  emergency  plans  referred to  in Article  11. 
b)  consult with  other  Member  States likely to  be  affected  in case  of 
an  accident  i11  the  drawing  up  and  implementation  of  emergency plans. 
c)  inform  the  Conunission  as  soon  as  possible  of  any  accident  within 
lhe  scope  of  this  Directive,  giving details  of  the  circumstances  of 
the  accident,  the  identity  and  quantities  of  the  microorganisms 
released,  the  emergency  response  measures  employed  and  their 
effectiveness,  and  an  analysis  of  the  accident  including 
recommendations  for  the  limitation of its effects  and  the  avoidanc~ of 
similar accidents  in the  future. 
7.  'l'he  Commission,  shall  est<1blish  a  procedlll:c  for  the  exchanc:_w  of 
information  under  paragraph  1)  above.  It shall  also  set  up  and  keep 
at  the disposal  of  the  Member  States  a  register of  the  accidents  which 
have  occurred  under  the Directive,  including an  analysis  of  the  causes 
of  the accidents,  experience gained,  and  measures  taken  to  avoid 
similar accidents  in  the  future. 
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ARTICLE  14 
1.  Every  three years,  Member  States  shall  send  the  Commission  a 
summary  report  on  their experience with this Directive,  the first time 
being  on  1st September  1991. 
2.  Every  three years,  the  Commission  shall publish  a  summary  based  on 
the  report referred to in paragraph  1,  the first time  being in  1992. 
3.  The  Commission  may 
implementation  of  this 
contains  no  information 
competitive position of  a 
publish general statistical information  on  the 
Directive and  related matters,  as  long as it 
likely  to  cause  substantial  harm  to  the 
user. 
ARTICLE  15 
1.  The  Commission  shall  be  assisted  by  a  committee  of 
nature  composed  of  the  representatives  of  the  Member 
chaired by the representative of  the Commission. 
an  advisory 
States  and 
2.  Amendments  made  to  the  annexes  of  this Directive to adapt  them  to 
technical  progress  shall  be  adopted  by the  Commission  in accordance 
with  the  procedure  laid down  in Article  16. 
ARTICLE  16 
Where  the procedure  laid  down  in  this  Article  is  followed,  the 
representative  of  the  Commission  shall  submit to  the  Committee  a  draft 
of  the measures  to  be  taken.  The  committee  shall deliver its opinion 
on  the draft,  within  a  time  limit  which  the  chairman  may  ·lay down 
according  to the urgency of  the matter,  if necessary by taking  a  vote. 
The  opinion shall be  recorded in the minutes;  in addition,  each Member 
State  shall have  the right to ask  to  have its position recorded  in the 
minutes.  The  Commission  shall take  the  utmost  account  of  the  opinion 
delivered  by  the  Committee.  It shall  inform the  Committee  of  the 
manner  in which  its opinion  has  been  taken  into account. 
ARTICLE  17 
1.  Menilier  States  shall  bring  into 
administrativ~  provisions  necessary 
by ..... 
force  the 
to  comply 
laws,  regulations  and 
wi  t.h  this  Directive 
2.  The  Member  States  shall  immediat.ely 
laws,  regulations  and  admistrative 
inform  the  Conm1ission  of  all 
provisions·  adopted  in 
implementation  of  this  Directive. 
ARTICLE  18 





ANNEX  I 
CRITERIA  FOR  CLASSIFYING  GENETICALLY  MANIPULATED  MICROORGANISMS  IN 
GROUP  I 
Host  or parental orqanism 
- Non-pathogenic, 
No  adventitious agents, 
Proven history of  extensive safe use  or 
Built-in  environmental  limitations  permitting  optimal  growth  in 
the  reactor  or  fermenter  but  limited  survival  without  adverse 
consequences  in environment. 
Vector/Insert 
- Well  characterised and  free  from  Known  harmful  sequences, 
Limited  in size  as  much  as  possible to  the  DNA  required to perform 
the intended  function, 
Should  not  increase  the  stability  of  the  construct  in  the 
environment  (unless  that is a  requirement of  intended  function), 
- Should  be  poorly mobilisable, 
Should  not  transfer  any resistance  markers  to  microorganisms  not 
knmm  to  acquire  them  naturally  (if  such  acquisition  could 
compromise  use  of  drug  to control disease agents). 
Genetjcally manipulated  microorganism 
Non-pathogenic, 
As  safe in  the  reactor  or  fermenter 
but  with  limited  survi~al without 
enviroment. 
as  host or parental organism, 
adverse  consequences  in the 
Other  classes  of  microorganisms  that  could  be  included  in Group  I  if 
they are not  pathogenic  are: 
those  constructed  entirely  from  a  single  prokaryotic  host 
(including  .its  indegenous  plasmids  and  viruses)  or  from  a  single 
eukariotic  host  <including its chloroplasts,  mitochondria,  plasmids, 
but  excluding viruses), 
those  that consist  entirely of  DNA  segments  from different species 
that exchange  DNA  by  known  physiological  processes. 
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ANNEX  II 
Points  to consider in conducting the  safety  assessment  referred to in 
Article  4. 
A.  Characteristics of  the parental microorqanism<s> 
B.  Characteristics of  the modified mjcroorqanism 
C.  Health  considerations 
D.  Environmental  considerations 
A.  Characteristics of  the parental microorqanism<s> 
Names  and  designation, 
Degree  of  relatedness, 
Sources  of  the microorganism<s> 
Information  on  reproductive 




History of  prior genetic manipulations, 
(sexual/asexual> 





Stability  of·parental  or of  recipient microorganism  in  term  of 
relevant genetic traits, 
Nature  of  pathogenicity  and virulence,  infectivity,  toxicity and 
vectors, 
Host  range, 
Other potentially significant physiological traits, 
Stability of  these traits, 
Natural.  habitat  and  geographic  distribution.  Climatic 
characteristics of  original habitats, 
Significant involvement in environmental processes, 
· Interaction  with  and  effects  on  other  organisms  in  the 
environment, 
Ability to  form  survival structures. 
B.  Characteristics of  the modified microorqanism 
The  nature  of  the modification, 
the  functlon  of  the genetic  manipulation or  of  the  new  nucleic 
acid, 
Nature  and  source  of  the vector, 
Structure  and  amount  of  any  vector  and/or 
remaining  in  the  final  construction 
donor 
of 
nucleic  acid 
the  ·modified 
microorganism, 
Stability of  the  microorganism  in  term of  genetic traits, 
Frequency  of  mobilisation  of  inserted  vector  and/or  genetic 
transfer capability, 
Rate  and  level of  expression of  the  new  genetic material, 
Activity of  the  expressed protein. 
C.  Health  considerations 
Allergenic  and  toxic  hazard  of  the  protein  or  of  non-viable 
microorganism, 
Comparison  of  the  modified  microorganism 
microorganism  regarding pathogenicity, 
Capacity for  colonisation, 
to  the  parent 
'· If  the  microorganism  is 
immunocompetent: 
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pathogenic.  to  humans  who  are 
a)  Diseases  caused  and  mechanism  of  pathogenicity  including 
invasiveness  and virulence, 
b)  Communicability,  · 
c)  Infective dose, 
d)  Host  range,  possibility of alteration, 
e)  Possibility of  survival outside of  human  host, 
f>  Presence of  vectors  or means  of  dissemination, 
g>  Biological stability, 
h>  Antibiotic-resistance patterns, 
i>  Allergenicity, 
j}  Availibity of  appropriate therapies. 
D.  Environmental  considerations 
Factors  affecting survival  and multiplication  of  the  engineered 
microorganism in the environment, 
Available  techniques  for  detection,  identification  and 
monitoring of  the  engineered microorganism, 
Available  techniques  for  detecting transfer  of  the  new  genetic 
material  to other organisms,  · 
Known  and  predicted habitats  of the engineered microorganism, 
Description  of  ecosystems  to  which  the  microorganism  could  be 
accidentally disseminated, 
Anticipated  mechanism  and  result  of  interaction  between  the 
engineered  microorganism  and  the  organisms  or  microorganisms 
which  might  be  exposed in case of  release to  the environment, 
Known  or  predicted  effects  on  plants  and  animals  such  as 
pathogenicity,  infectivity,  toxicity,  virulence,  vector  of 
pathogen,  allergenicity,  colonisation, 
Known  or predicted  involvement  in  biogeochemical  processes, 
Availability  of  methods  for decontamination  of  the area in  case  of 
release to the  enviionment. - 4  -
ANNEX  III . 
The  containment measures  for microorganisms  from  Group  II shall  be 
chosen  by  the  user  from  the categories  below as  appropriate to the 
microorganism  and  the  operation in  question in  order to  ensure the 
protection  of  the  public health  of  the  general population  and  the 
environment. 
_Industrial  .uses  shall be  considered in terms  of  their unit operations. 
The  characteristics  of  each  operation  will  dictate=  the  physical 
containment  ·to be  used at  that stage.  This  will allow.selection and 
design  of  process,  plant and  operating  procedures  best  fitted  to 
assure  adequate  and  safe containment.  Two  important  factors  ·to be 
considered  when  selecting  the  equipment  needed  to  implement- the 
containment  are the  risk of·,  and  the effects· consequent  on;  equipment· 
failure.  Engineering  practice  may  require  increasingly.  stringent 
standards  to reduce  the risk  of  failure  as  the  consequence  of  that 
failure becomes  less tolerable. 
Containment  measures  for  non-industrial  scale  operations  shall  be 
deriyed  from  the  containment  categories  below,  bearing  in mind  the 
specific circumstances  of  smaller-scale operations. 
-
SPECIFICATIONS 
1.  Viable  microorganisms  should 
in  a  system which  physically 
separates  the process  from  the 
environment  <closed  system) 
2.  Exhausted  gases  from  the  closed 
system should  be  treated so  as  to: 
3.  Sample  collection,  addition of 
materials  to  ~  closed  system  and 
transfer of  viable microorganisms 
to another  closed  system,  should  be 
performed  so  as  to: 
4.  Bulk  culture fluids  should not 
be  removed  from  the  closed  system 
unless  the  viable microorganisms 
have  been: 
5.  Seals  should be  designed  so 
as  to: 
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6 ..  ~.Closed systems  should be 
located within  a  controlled area 
a)  Biohazard  signs  should be  posted 
b)  Access  should be  restricted to 
nominated  personnel only 
c)  Personnel  should wear protective 
clothing 
d>  Decontamination and washing 
facilities  should  be  provided 
for personnel 
e)  Personnel-should  shower  before 
leaving  the controlled area 
f)  Effluent from  sinks  and  showers 
should  be collected and  inactived 
before release 
g)  The  controlled area  should  be 
adequately ventilated to minimise 
air contamination 
h>  The  controlled area  should  be 
maintained at an air pressure 
negative  to  atmosphere 
i>  Input air and extract air to 
the  controlled area  should  be 
HEPA  filtered 
j)  The  controlled area  should  be 
designed  to contain spillage of 
the entire contents  of  the 
closed  system 
k)  The  controlled area  should be 
sealable to permit  fumigation 
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ANNEX  IV' 
PART  A  - Information  required  for  the  declaration  referred  to 
in Article  6 
- name  of  person(s)  responsible  for  carrying out the contained  use; 
- description  of  the  education and  training received  by the persons 
who  will carry  out the  work,  of  the persons  who  will take part in 
them,  of  the  persons  who  will  be  responsible  for  supervision, 
monitoring  and  safety and  of  the person responsible  for carrying out 
the safety assessment; 
- the address  of the  installation; 
- a  description of  the nature of  the  work  which will be  undertaken  and 
in  particular the  classification of  the microorganism(s)  to be  used 
and  the likely scale of the  operation. 
PART  B  - Information  required  for  the  notification  referred  to 
in Article  7.2 
- the date  of  submission of  the declaration referred to in  Article  6; 
- the  parental microorganism(s)  used or,  where  applicable  the host-
vector  system(s)  used; 
- the  source(s)  and  the  intended  function(s)  of  the  genetic 
material(s)  involved  in the manipulation(s) 
- the  purpose  of  the  contained use  including  the expected  results; 
- the culture volumes  to be  used. 
PART  C  - Information  required  for  the  notification  referred  to 
in Article  8.1 
the  information required in Part B 
- description  of  the  sections  of  the  installation, 
predominant  meteorological  conditions  and  of  the potential 
of  danger  arising  from  the  location of  the  installation; 
description  of  the  protective  and  supervisory  measures 
applied throughout  the duration of  the  contained use; 
- the  safety  precautions  and  containment  measures  to  be 
including waste  treatment  provisions. 
of  the 
sources 
to  be 
adopted 
PART  D  - Information  required  for  the  notification  referred  to 
in Article  8.2 
If  it is  not  technically  possible or if it does  not  appear  necessary 
to  give  1~he  information  specified  below,  the  reasons  shall  be  stated. 
The  level  of  detail  required  in  response  to  each  subset  of 
considerations  is  likely to  vary according  to  the nature  and  the  scale 
of  the  proposed  contained use.  In  the  case  of  information already 
submitted  to  the  competent  authority  under  the  requirements  of  this 
Oj_rective,  reference  can  be  made  to this  information  by  the  user. 
a l  the  date  of  sub111.i.ssion  of  the declaration  ro£e1:red  to  in  Article  G 
and  the  name  of  the iesponsible  person<s> 
;_z ··'  . •. 




b)  information about  the microorganj,sm(s): 
- the identity and  characteristi~~.;. of  the microorganism<s), 
- the purpose of  the contained use·:or  the nature of  the product; 
-the host-:vector  system to be  usedi..;..Cwhere  applicable>; 
the volumes  to  be  used;  '  '·:.· 
behaviour  an·d  characteristics  of .....  ,.·~pe  microorganism< s)  in  the 
case  of  changes  in the  condition~~bf  containment  or of  release 
to the  environment,  \~  ·~  .. 
- overview  of  the  potential hazards  a~iQciated with  the release of 
the microorganism(s)  to the  environmen't;~.~ 
- substances  which  are  or may  be  producifr in the  course of  the use 
of  the microorganism  ( s)  other than the  ±nt:ended  product. 
J  ~  • 
\·. 
c)  information about  personnel: 
\  -. 
the  maximum  number 
the  number  of 
of  persons 
persons 
working  i~,  the installation 
who  work  \directly  with 
and 
the 
microorganism(s).  \ 
d)  information about  the installation: 
the activity in which  the microorganism(s)  is to  be  used; 
- the technological  processes  used, 
- a  description of  the sections  of  the installation, 
- the  predominant meteorological  conditions,  and  sources  of  danger 
arising  from  the  location of  the  installation. 
e)  information about waste management: 
- types,  quantities,  and  potential hazards  of wastes  arising  from 
the  use  of  the microorganism(s), 
- waste  management  techniques  used 1  including  recovery,  liquid or 
solid wastes, 
- ultimate  form  and  destination of  inactivated wastes. 
f)  information 
plans: 
about  accident  prevention  and  emergency  response 
the  sources  of  hazards  and  conditions  under  which  accidents 
might  occur; 
- t:he  prevent.ive  measures  applied  such 
systems,  containment  methods  and 
resources, 
as  safety equipment,  alarm 
procedures  and  available 
- a  description of  information provided  to workers; 
- the  information  necessary  for  the  competent  authority to  enable 
them  to draw  up  or  establish the  necessary emergency  response 
plans  for  use  outside  the  installation  in  accordance  with 
Article  11 
l})  a  comprehensive  assessment 
potential  hazards  and  risks 
contained  use. 
(referred  to  in 
which  might  arise 
l~r  t i c 1 e  4:  ) 
from  the 
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EXPLANATORY  MEMORANDUM 
I.  INTRODUCTION 
In  its  Communication  to  the  Council  "A  Community 
Framework  for  the  Regulation  of  biotechnology" 
<Com<86>573  final),  the Commission  signaled its intention 
.to  introduce  proposals  for  Community  Regulation  of 
biotechnology which  would  address two.distinct aspects  of 
the use  of  genetic engineering: 
A.  Levels  of  physical  and 
accident  control  and waste 
applications; 
biological  containment, 
management  in industrial 
B.  Authorization  of  planned  release  of  genetically 
engineered organisms  into the environment. 
The  current  proposal  concerns  the  release  into  the 
environment  (aspect  B).  Industrial  applications  (aspect 
A}  will  be  the subject of  separate proposals. 
The  deliberate  release  into  the  environment  of 
genetically modified  organisms  (GMOs}  has  given rise to 
parbicularly intense  debate  ~bout  the  possible  risks 
involved.  The  application of  th~se organisms  in the  open 
environment  is  very  broad:  pesticides,  herbicides, 
nitrogen fixation  <in  microorganisms  or in crop-plants), 
plants  and  animals  resistant  to  pests·  and  diseases, 
adapted to  extreme meteorological  conditions  or scarcity 
of  resources,  degradation of  toxic  chemicals  and  oil 
spills,  enhanced  oil recovery,  metal  leaching  of  low-
grade ores,  and  many  bthers. - 2  -
At  the  same  time,  however,  the  intentional release  of 
organisms  having  a  combination of  traits that nature may 
have never  produced  increases uncertainty as  regards  the 
behaviour of  the  organism  and  the  possibility  of  a 
deleterious  impact  on  the environment.  Not  only known  or 
predicted traits  of  the organism  (such  as  pathogeniticy, 
etc.)  may  raise questions  but also  the possibility  of 
displacement  of  natural  populations,  ·alteration  of 
ecological  cycles  and  interactions,  and  undesired 
transference of  novel  genetic  traits to  other  species 
(i.e., pesticide-resistance  of  a  crop-plant passed  on  to 
weeds).  This  makes  it  necessary  to  proceed  with  the 
releases  in  a  careful  manner.  Therefore,  regulatory 
measures  are  needed to  ensure that  these  releases  be 
carried  out  only  under  conditions  of  human  and 
environmental  safety  which  are  as  high  as  reasonably 
practicable. 
It must  also be  adknowledged that the use  of  GMOs  could 
lead to  improvements  in  helath and  the environment  by 
permitting the  development  of  more  precise agricultural 
inputs  for  protection and  nutrition and  more  effective 
treatment of waste. 
A  recent  OECD  report  ("Recombinant  DNA  safety 
considerations",l986>  recognized  the. risks  mentioned 
above  and  concluded that  they can  be assessed,  to  some 
extent,  by  analogy  with  information  about  existing 
organisms.  However,  there is  insufficient experience at 
this stage  provide  a  basis  for  coherent standards  for 
testing and  regulations.  Instead,  the Report  recommends  a 
prior case-by-case evaluation of all deliberate releases. 
The  Commission  believes that  the  rapid elaboration of  a 
Community  framework  of  biotechnolgy  regulation  is  of 
crucial  importance  to  the  development  of  this  new 
technology in the  Community.  Citizens  and  the environment 
throughout  the  Con®unity  need  to  be  provided  with 
adequate  protection  from  any  potential hazards  arising 
from  the application of  genetic engineering.  The  internal 
market  arguments  for  Community-wide  regulation in  this 
field are  clear and,  from  an  environmental  viewpoint, 
organisms  are  no  respecters  of  national  frontiers,  and 
nothing  short  of  Community-wide  regulation can offer the 
necessary human  and  environmental  protection. 
Because  international experience  in deliberate release is 
still limited,  it is not  possible  to propose  any general 
guidelines  or  testing requirements  for  the  time  being. 
'!'he  Commission  is  therefore  proposing  a  case-by-case 
notification-and-endorsement  procedure  which  will  be 
mandatory  for  industry and  research institutions,  in line 
with the  recommendation  of  the  OECD  report. 
.r:-:·  r:· 
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II.  LEGISLATIION  IN  THE  MEMBER  STATES  OF  THE  EUROPEAN 
COMMUNITY 
Several  Member  States  have  been  reviewing  existing 
regulations  and  generally assessing  the risks to humans 
and  the  environment  from  the  release  of  genetically 
engineered organisms. 
In the  Federal  Republic  of  Germany  a  general  ban  on  the 
deliberate  release  of  genetically  modified  organisms 
(GMOs)  has  been established.  ~xemptions are  on  a  case-by-
case basis,  without any  formal  authorization procedures. 
The  German  authorities are  currently deciding whether  a 
legal  framework  is neceesary  to  reg~late the deliberate 
release of  GMOs,  taking  into account  a  recent Bundestag 
report on  the subject. 
In  Italy,  no  specific  regulation  applies  to  the 
deliberate release  of  GMOs.  A first proposal  for release 
is being  examined under pesticide legislation. 
In  The  Netherlands,  regulations  for environmental release 
are in  preparation.  At  present,  there  is  no  ban  on  the 
release of  GMOs;  the  Government  aliows  experiments  to 
proceed where  adequate  review has  been provided. 
In France,  the Ministry of Agriculture has  established a 
commission  <Commission  de  Genie  Biomoleculaire>  to 
examine  case-by-case  the deliberate release of  GMOs. 
Belgium is  covering  GMOs  under  existing  legislation, 
having gained.  some  experience with  a  proposed release of 
genetically modified potato plants: 
·Luxembourg is examining closely the deliberate release of 
GMOs.  The  possibility of  ad  hoc  authorizations will be 
exa~ined by  the Ministry of  the  Environment. 
In  the  United  Kingdom,  guidelines  for  the  deliberate 
relase  of  GMOs  were  approved  in  April  1986.  These 
guidelines,  prepared  by the Advisory Committee  on  Genetic 
Manipulation  <ACGM>  establish a  framework  for  the case-
by-case consideration ·  of  proposals  by an  expert national 
body and  ·relevant governmental  departments,  and  has  set 
up  a  sub-committee to  oversee  individual notifications. 
This  scheme  is at  present voluntary,  but the  ACGM  has 
proposed  statutory notification for deliberate releases. 
2t· - 4 
The  guidelines,  which will  apply to  organisms  obtained 
through genetic  manipulation,  will  cover releases to the 
environment  in  large scale  and  field  trials under  non-
contained conditions.  It is  envisaged  that  when  GMOs 
developed  for  release have  been  fully assessed  by ACGM, 
HSE  and  other relevant governemental  departments,  routine 
use will be  exempt  from  the notification procedure. 
In  Denmark,  the  Danish  Folketing adopted  in May  1986  a 
bill  on  genetic  engineering  and  other  technologies, 
including agricultural and  environmental uses  of  GMOs  and 
products  containing  them.  The  provisions  of  the  law 
state: 
- release of  GMOS  may  not  take  place even  for research 
purposes;  the  Ministry of  the  Environment  may  approve 
such releases in special cases; 
- applicant in  these cases  must,  if  so  required by the 
Authorities,  provide  information and  test results  in 
accordance  with  certain  guidelines  and  at  certain 
laboratories.  The  Ministry of  the  Environment  may  lay 
down  detailed  rules  on  the  implementations  of  the 
approval  arrangements; 
The  law covers: 
inspection,  information  on  accidents,  prohibition 
after  authorization  has  been  granted,  imported 
substances,  local  authorities  and  the possiblity of 
appeal  against  decisions  taken under  the  law. 
Ireland has  set up  a  Recombinant  DNA  Committee  and  an 
Institutional Biosafety  Committee.  Deliberate  releases 
will require  review and  approval  by  these  Committees, 
which  will  follow the  OECD  recommendations.  In addition, 
prov.isions  of  a  number  of  Irish  laws  are relevant in the 
cas~s  of  deliberate  releases,  including  the  Water 
Pollution Act,  the  Dangerous  Substances  Act  and  the 
Destructive  Insects  and  Pests Act. 
In  Greece,  there are  no  specific  regulations  in  this 
field,  but  an  'Ad  hoc  Committee  of  Biohazards'  has  been 
set  up  with  responsibility  in  the  coordination  of 
biosafety activities. 
In  Spain,  no  specific  regulations  apply  to  deliberate 
release of  GMOs,  but  a  committee  is being  set up  to be 
responsible of  these activities 
In  Portugal,  there are  no  specific  regulations in  the 
field but the Secretariat of State of  Environment will be 
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COMMENTS  ON  THIS  PROPOSAL  FOR  A  DIRECTIVE 
!.General 
The  possible  hazards  from  the release to .the environment 
of  genetically modified organisms are of various  types: 
- pathogenicity to humans,  animals  or plants; 
- disruptive effects  on  ecosystems 
natural populations,  alteration of 
and  interactions; 
displacement  of 
ecological  cycles 
transfer of  the novel  genetic traits to other species 
with undesired effects; 
- excessive  dependence 
variation. 
on  species  lacking  genetic 
However,  public  concern  about  genetic  engineering  is 
growing,  and  it is easy to  imagine  the public's response 
in case  of  harm to people or the environment  caused  by  a 
GMO  deliberately  introduced  in  the  environment. 
Moreover,  genetic  engineering will  sharply increase the 
number  of  organisms  with  new traits  intro9uced in  the 
environment.  These  reasons  make it urgently necessary to 
provide protection to people  and  the environment  from  the 
possible risks related to these new  techniques. 
The  present  approach,  which  focusses  on  the  new 
techniques  of  genetic engineering,  is the first and  most 
urgent  step in the regulatory process;  however,  this will 
not  impede  evolution  towards  a  more  organism-related 
approach.  Thus,  the  Commission  will,  as  experience and 
knowledge  on  the matter  build-up,  undertake  to regulate 
the  release  of  certain  categories of naturally-occuring 
organisms,  such  as  known  human,  plant  or  animal 
pathogens,  and  non-indigenous  organisms.  Moreover, 
different categories  of  organisms  and/or techniques  may 
be  established,  allowing  different  requirements  for 
organisms  of different levels  of  risk. 
This  Directive will establish a  case-by-case notification 
and  endorsement  procedure  for  the deliberate release of 
GMOs.  Before  carrying  out  a  release,  the  person 
responsible  for  it shall  submit  a  notification to  the 
Competent  Autho.ri ty  of  his  Member  State,  including  a 
detailed  risk  assessment  where  the  possible  hazards 
associated \vith  the  release must  be  identified. - 6  -
However,  understanding that there is a  clear quantitative 
difference in  the  level  of  risk  between  experimental 
releases  (carried  out under  very controlled conditions, 
strictly limited  in space  and  time,  closely  monitored) 
and  commercial  ones  <with  limitations only in areas  and 
conditions of  use),  two  different  procedures  will  be 
established:  one  for experimental  releases  where  each 
competent authority is fully responsible  for the releases 
carried out in its Member  State,  and  a  second  one  for the 
placing on  the market  of  genetically modified organisms 
for·a  given use,  where  consultation  and  agreement with 
the other  Member  States  is needed  before the  product is 
endorsed  for its placing on  the market. 
The  endorsement  procedure  has  the  advantage  over  an 
authorization procedure,  that it  leaves  responsibility 
with the  notifier.  Moreover,  in a  field  largely unknown 
like this,  the decisions  as  to  the safety of  a  release 
and its  conditions must  be  the  result of  a  dialogue 
between notifier and  Competent Authority. 
In  a  largely unexplored  field like this,  the exchange  of 
information is  likely  to  play  an  essential  role  in 
gaining experience.  Therefore,  provision  is  made  for 
information exchange  among  the Member  States  through the 
Commission.  This  information  sharing  will  be  without 
restriction  for  the  Commission  and  the  Competent 
Authorities,  provided  that absolute  confidentiality  is 
guaranteed  for  these  data.  The  experience  from  the 
chemicals  sector,  where  notification  units  for  new 
chemical  substances  have  been  working  for  years  with 
excellent results,  encourages  the  Commission  to  pursue 
this goal. 
On  the other hand,  given the public  concern  about  genetic 
engineering,  it  is  considered  essential  that  the 
information  necessary  for  evaluating  the  risk  and 
adopting  safety  measures,  be  made  available  to  the 
public. 
2.  Particular  comments 
Directive 
The  proposal  is 
<articles  1  to  3) 
<articles  4  to  7> 
for  research  and 
(articles  8  to  16) 
products  containing 
<articles  17  to  23) 
on  certain  articles  of  the 
divided  in  four  parts:  Part  A 
on  general  provisions,  Part  B 
on  the  deliberate release of  GMOs 
development  purposes,  Part  C 
on  the  placing  on  the market  of 
or consisting  of  GMOs,  Part  D 
on  final provisions. 
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PART  A:  GENERAL  PROVISIONS 
Article  2 
The definition  of  "organism"  encompasses  viruses  and 
other subcellular  entities as  well  as  higher plants 
and  animals.  It  is understood  that these organisms 
are living  ones,  including  inactive  forms  such  as 
seeds,  spores,  and  the like. 
Annex  I, which will be  updated  as  necessary,  indicates 
the  techniques  by  which  the  genetically  modified 
organisms  can  be obtained. 
"Deliberate  release"  is  defined  in  opposition  to 
"contained  use".  As  the  borderline  between  these 
concepts  is not clear-cut,  particularly in the case of 
greenhouses  and  stables  (which  can  be  considered 
contained or  non-contained depending  on  the adoption 
of  particular measures  or on  certain characteristics), 
and  taking  into account  the need  to establish clear 
criteria  to  trigger  the  notification  under  this 
Directive,  the  Commission  will  elaborate,  in 
consultation  with the  Member  states,  guidelines  for 
containment  in  greenhouses,  stables  and  other 
facilities,  which  will clarify  which activities will 
be  considerd as deliberate release. 
PART  B:  DELIBERATE  RELEASES  FOR  EXPERIMENTAL  PURPOSES 
Article  4 
This Article  establishes  the obligation to notify all 
releases  in  the  research  and  development  phase  and 
outline~ the content  of  the notification. 
One  of  the most  important  features  of  the  procedure  of 
notification is  that it promotes  the dialogue  between 
notifier and  Competent  Authority.  This  dialogue will 
serve to clarify all those  cases  where  the application 
of  the  Directive is in doubt. 
Article  5 
This  Article  establishes  that  national  Competent 
Authorities will  be  in  charge  of  the  review  of  the 
notifications  and  their endorsement.  The  Commission 
may  establish  regular contacts  and  interchanges  among 
the different  Competent  Authorities,  or carry out  any 
other relevant activities in order to ensure  a  uniform 
and high-quality review by all Competent Authorities. 
', i. - 8  -
Article  6 
This  Article  establishes  the  endorsement  of  a 
notification  for  an  experimental  release  by  the 
national  Competent Authority.  The  Competent Authority, 
in order  to endorse  a  notification,  will have  to be 
satisfied not  only with  the  formal  compliance of  the 
dossier with  the Directive  but,  above all, will have 
to consider  the  risk  associated  with  the  release 
acceptable. 
Article  7 
This article establishes the procedure  for information 
exchange  among  Competent Authorites 
£ART  C:  PLACING  ON  THE  MARKET  OF  PRODUCTS  CONTAINING 
OR  CONSISTING  OF  G~Os 
Article  9  and  10 
In these  articles,  the procedure  for notification and 
endorsement  for  the placing on  the market  of  products 
consisting of  or containing  GMOs  is  laid down.  As 
these  products  must  be  able  to  circulate  in  the 
Community  without  trade  barriers,  provisions  for 
consultation among  Member  States  are considered,  so 
that no  product  shall  be  endorsed without all Member 
States  having  had  the right to object. 
However,  taking  into  account  the  high  specificity 
expected  for most  of  these products,  and  the diversity 
of  environments  within the  Community,  the  endorsement 
is made  valid only  for  the  use  of  the  product  under 
very  specific  conditions  and,  where  relevant,  in 
specific geographical areas. 
In  cases  where  the experimental  phase  has  demonstrated 
that the  product to  be  notified  is very  safe,  the 
notifier may  ask  not  to  comply with  some  notification 
requirements  so  as  to  simplify the endorsement  of  the 
product. 
Article  12 
This  article  establishes that products  endorsed  under 
this  Directive must  be  commercialized  under  conditions 
which  ensure their proper  and  safe use. 
r 
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Article  13 
This  Article  establishes  the  free  circulation  of 
products  containing  genetically  modified  . organisms 
which  have  been properly endorsed. 
Article  14 
This  is  the safeguard  clause,  which  allows  Member 
Sates  to  impose  provisional  measures  on  the 
commercialization of  products  containing  GMOs,  until 
the Commission  takes  a  Community-wide decision.  The 
reasons  for  a  national  ban  should  in  any  case  b~  ·  ··· 
~cientific ones.  · 
PART  D:  FINAL  PROVISIONS 
Article  17 
This article  establishes the right of  the notifier to 
determine,  to  a  certain extent,  the  information within 
the notification  which  is  to be  kept secret  (except 
for the  Commission and  the  Competent Authorities) oin 
order to  safeguard his  competitive position.  But,  at 
the  same  iime,  it  establishes  a  minimum  set of data 
that,.in  any case,  has  to  be made·  available to the 
public.  This  ac~ounts  for the  citizen's  right  to 
information about  potentially harmful  activities,  and 
will also  help to  promote public's confidence in the 
development  of  genetic engineering. 
Article  18 
This Article  establishes the  commitment  to update the 
Oirective to  technical progress  as  necessary,  given 
ihe rapid scientific development  of this  field. 
Article  19 
Committee  which  will 
application  of  the 
annexes  to technical 
of  disputes  before 
This article  establishes  the 
advise  .the  Commission  in  the 
A~ticle 14,  the adaptation of  the 
progress  and  the  resolution 
endorsement. 
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Annex  I 
This Annex  is intended  to provide,  through  a  periodical 
update,  as  a  clarification of what  techniques  can make  an 
organism  "genetically  modified"  within  the  meaning  of 
this Directive  ..  The  techniques not  covered are those.that 
have  long  been  used  with  crop plants  and  livestock with 
an excellent safety record. 
Annex  II 
This  Annex  sets out the  information requirements  for the 
notification.  It  is not  a  checklist,  for not all items 
are relevant  in every case.  Instead,  it is intended as  a 
comprehensive list  of.different aspects relevant for the 
evaluation of  the risk,  from which  each notifier  will 
pick those  items  which  are relevant to their case. 
The  level  o;f  detail· of  the  inf.ormation to  .. be  provided  and 
its quality  will be  a  function of  the type of  release:  a 
field test  is likely  to rely  heavily on  bibliographic 
data  and  assumptions,  whereas  a  notifi.cation  for  a 
product  should  be  based  on  experimental  evidence. 
Competent  Authorities  will  therefore  examine  the 
information .requirements in  a  flexible manner. 
Annex  III 
This  Annex  specifies the additional information required 
in the notification dossier in the  case of  the placing on 
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PROPOSAL·. 
FOR  'A 
.  COUNCIL  DIRECTIVE  ON  THE  DELIBERATE  RELEASE  INTO  THE 
ENVIRONMENT  OF  GENETICALLY  MODIFIED  ORGANISMS 
THE  COUNCIL  OF  THE  EUROPEAN  C9MMUNITIES, 
Having  regard to the  Treaty ~Establishing the. European· Economi.c 
Community  and  in particular Ar~icle lOOA  thereof, 
Having  regard to the proposal of  the  Commission  (1), 
Having  regard to the opinion of,the European  Parliament  <2>,-
Having  regard  to  the  opinion  of  the  Economic  and  Social 
Committee  <3>, 
Whereas,  disparity between  th~ regulation  of  the  deliberate 
release  to  the  environment of  genetically modified  organis~s 
which  are  in effect or  in preparation in the Member  States  may 
create  unequal  conditions  .'of  competition  and  thus  directly 
affect  the  functioning  of  the  common  market;.  whereas,  it is 
therefore  necessary to  approximate  the  laws  of.  the  Member 
States  in this  regard,  as ~rovidSd for  in Article  lOOA  of  the 
Treaty; 
l'lhereas  measures  for  the approximation  o'f  the  provisions  o'f 
the  Hember  States which  have  as  their object the  establishment 
and  functioning  of  the  internal market  shall,  inasmuch  as 
they  concern  health,  safety,  environmental  and  consumer 
protection,  take  a  . high  level  of protection as  a  base  <5>  and 
provide,  _despite  existing  differences  in  economies  of  the 
Member  States,  for  equal  standards  of  protection  throughout 
the  Community;  ..  _. 
Whereas  under  the  Treaty,  action by the  Community  relating to 
the  ·  environment  shall  be  based  on  the  principle  that 
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Whereas  living organisms,  whether released to the environment 
in  large or  small  amounts  for  experimental  purposes  or  as 
commercial  products,  may  reproduce  in  the  environment  and 
cross  national  frontiers  thereby affecting  bordering  Member 
States or the  Community as  a  whole, 
Whereas  it  is  necessary  to  ensure  the  development  of 
industrial  products utilizing  genetically modified  organisms 
which  do  not  cause harm  to human  health or the environment, 
whereas  the new  biotechnology promises  improvements  in health 
and  the environment  by developing  more  precise  agricultural 
inputs  for  protection  and  nutrition  and  more  effective 
treatment of wastes. 
Whereas  the protection  of  the  public  and  the  environment 
requires  that due attention be  given to controlling risks  from 
the  deliberate release  of genetically  modified organisms  to 
the environment, 
Whareas  new  techniqes  of genetic  modification are defined  in 
Article  2.2  and  Annex  I  of  this  Directive;  whereas  those 
techniques  which  have  conventionally  been  used  with  crop 
plants  and  livestock  with  an  excellent safety record are not 
covered  by the definition of Article'2.2 or Annex  I; 
Whereas  it is necessary to establish harmonized  procedures 
the  evaluation  of  the  po'tentfal  risks  arising  from 
intentional  introduction,  for  the  purpose  of  research 






Whereas,  the  deliberate  rel~ase.  of  genetically  modified 
organisms  at the  research stage  is in most  cases  a  necessary 
step  in the  development  of  new  ·products  derived  from  or 
containing  genetically modified  organisms;  and  whereas  the 
regulatory  requirements  under  which  these releases  take place 
are  likely to  have  important  impacts  on  the  final  cost of  such 
products;  , 
Whereas  it it  necessary to  establish a  Community  review and 
decisionmaking  procedure  for  the placing  on  the market  of  the 
products  containing  or  consisting  of  genetically  modified 
organisms,  where  the intended use  of  that product  involves its 
deliberate release to the  environment, 
Whereas  any  person,  before  undertaking  a  new  deliberate 
release  to the environment of  a  genetically modified  organism, 
or  the placing  on  the  market  of  a  product  containing  or 
consisting  of  genetically  modified  organisms  where  the 
intented  use  of  that product  involves its deliberate release 
to  the  environment,  shall  submit  a  notification  to  the 
national  competent authority, 
Jb 
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Whereas  that notification  should contain  a  technical dossier 
of  information including  a  full  risk assessment,  appropriate 
safety  and  emergency  response,  and  in the  case of  products, 
precise  instructions and  conditions  for  use,  and  proposed 
labelling and  packaging 
Whereas,  it is important to  follow closely the development  and 
use  of genetically modified organisms,  and that in order to do 
this  it is  necessary to  list all the products notified under 
this  Directive,  and  to provide  for  subsequent  notifications 
and  follow-up  information, 
Whereas,  .when  a  product  containing  a  genetically  modified 
organism  or a  combination of  them is  placed on  the  market 
where  the intended use of  that product involves its deliberate 
release  to the  environment,  and where  such  a  product has  been 
properly  notified and  endorsed under this Directive,  a  Member 
State  may  not  prohibit,  restrict  or  impede  the  deliberate 
release  of  this  organism  on  their  territory  under  the 
conditions  set out  in  the  notification,  except  under  the 
specific  conditions of  .a safeguard  procedure,  in  case of  a 
serious  risk to  human  health or the environment; 
HAS  ADOPTED  THIS  DIRECTIVE: 
PART  A:  GENERAL  PROVISIONS 
ARTICLE  1 
1.  The  objective of  this Directive is to approximate  the  laws, 
regulations  and  administrative  provisions  of  the  Member 
States  and  to  protect the health of  the general  population 
and  the environment  in relation with: 
the  deliberate release  of  genetically modified  organisms 
to the environment, 
- the  ~placing on  the  market  of  products  containing  or 
consisting  of  genetically modified  organisms  intended for 
subsequent deliberate release to the environment. 
2.  This  Directive  does 
genetically modified 
waterway,  sea  or air. 
not  apply 
organisms  by 
ARTICLE  2 
For  the  purpose  of  this Directive: 
to  the 
rail, 
carriage  of 
road,  inland 
1.  Organism  includes multicellular  and  unicellular organisms. 
It  also  includes  subcellular  entities  capable  of 
replication. 
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2.  Genetically  modified  organism  (hereinafter referred  to as 
GMO)  is an  organism  in  which  the  genetic  material  is 
altered  in a  way that passes  the natural barriers  of mating 
and  recombination.  Annex  I  indicates  the  techniques  by 
which  such genetic alterations  can be  obtained. 
3.  Deliberate  release means  any intentional  introduction  in 
the environment  of  a  GMO  or  a  combination of  GMOs  without 
provisions  for  containment  such  as  special procedures, 
equipment  and  installations,  or  facilities  that  provide 
physical  barriers  to  prevent  their  spread  into  the 
environment. 
4.  Product  means  a  preparation or formulation  consisting of or 
containing  a  GMO  or a  combination of  GMOs,  which  is placed 
on  the market. 
5.  Placing  on  the  market  means  supplying or making  available 
to third  parties  for  the  purpose  of  sale  or 
commercial distribution. 
6.  Notification  means  the  documents  whereby the person who  is 
to  carry  out  a  deliberate  release  of  a  GMO  or  a 
combination  or  GMOs  for  the  purpose  of  research  and 
development,  or to  place  a  product  on  the market  presents 
the  requisite information  to the  competent authority of  a 
Member  State.  This  person  shall be  referred to  as  "the 
notifier" 
7.~ means  the  deliberate release  of  a  product which  have 
been  placed  on  the market.  The  persons  carrying out this 
use will be  referred to as  "users". 
ARTICLE  3 
1.  Member  States  shall  adopt  the  provisions  necessary  to 
ensure  ~  that all persons  carrying out the deliberate release 
or  placing on  the market  of  GMO(s)  shall take all measures 
reasonably  practicable to  control  any  risk  of  harm  to 
people  and  the  environment. 
2 .. Member  States  shall  designate  the  competent authority  or 
authorities  responsible  for  carrying out  the  requirements 
of  this Directive and  its annexes. 
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PART  B:  DELIBERATE  RELEASE  OF  GENETICALLY  MODIFIED  ORGANISMS 
TO  THE  ENVIRONMENT  FOR  RESEARCH  AND  DEVELOPMENT 
PURPOSES 
ARTICLE  4 
Member  States shall  adopt  the  provisions  necessary to ensure 
that: 
1.  Any  person,  before  undertaking  a 
GMO  or  a  combination of  GMOs  for 
and  development,  must  submit 
competent  authority specified  in 
State  within whose  territory the 
before carrying out the release. 
2.  The  notification shall include: 
deliberate release  of  a 
the purpose of research 
a  notification  to  the 
Article 3.2  of  the Member 
release is to take plate 
a)  A  technical dossier  supplying  the information  specified in 
Annex  II necessary  for evaluating  the  foreseeable  risks, 
whether  immediate or  delayed,  which  the GMO(s)  may  pose to 
people  or the  environment,  together  with the methods  used 
and  the bibliographic  reference to  them  and  covering,  in 
particular: 
-identification and  characteristics of the GMO(s), 
the  location of  the area where  the·deliberate release is 
to be  carried out  and  the  predominant  meteorological, 
social,  environmental  and  agricultural characteristics of 
the area, 
- the  purpose  and  conditions  of  the release,  including the 
quantity  of  the  GMO(s)  to  be  released,  the size of  the 
area ,affected,  and  the duration of  the release, 
- all other  information necessary for risk assessment, 
methods  for monitoring  the  GMO(s)  and,  when  appropriate, 
proposed  techniques  for  ~limination or  inactivation  of 
the  GMO(s)  at  the  end  of  the  experiment,·  and  for 
emergency  response in  case  of  the  spread  df  the  GMOs 
beyond  the area  of  release. 
b)  A  statement evaluating  the  impacts  and  risks  posed  by  the 
GMOs  to  people  or the environment  from  the  uses  envisaged. 
3.  The  experimental  release of  a  combination of different  GMOs 
for  the  same  purpose  may  be  · notified  in  a  single 
notification. .  ~n· . 
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4.  In  the case  of  a  subsequent release  of  the  same  GMO  or 
combination  of  GMOs  previously notified as part of  the  same 
research  programme,  the  notifier  shall  be  required  to 
submit  a  new notification.  In this  case,  the notifier may 
refer  to data  from  previous  notifications or results  from 
previous  releases. 
5.  The  notifier 
notifications 
provided  that 
writing. 
may  also  refer  to  data  or  results  from 
previously  submitted  by  other  notifiers, 
the  latter have  given  their  agreement  in 
6.  In  the event  of  any modification of  the deliberate release 
of  GMO(s)  which  could have  consequences  with regard to the 
risks  for people  or the  environment or if new  information 
has  become  available  on  such  risks,  either  while  the 
notification  is being examined .by  the  competent authorities 
or after the endorsement,  the notifier shall:· 
a)  revise the measures  specified in Article 4.2 
b)  inform  the  competent  authority of  the modification,  in 
advance  or as  soon as  the  new  information is available, 
in  so  far as it affects the information contained in the 
notification. 
ARTICLE  5 
1.  The  competent  autho+ity shall: 
evaluate  the  risk  posed  by  the release  in the  light of 
the notifier's risk assessment, 
- state its conclusions  in writing, 
-,~and,  if necessary, 
- ask  : the  notifier  to  provide  further·.  information  or 
verification tests,  explaining the  reasons  for it, 
7 
- carry  out  such  te~~s as  may  be  necessary  fo{  cqntrol 
purposes. 
2.  The·_ competent  authority  shall respond  to the  notificatio~ 
within  90  days  of  its  receipt,  either  deciding  on  its 
endorsement  or indicating  the  further  information required 
or measures  to·be taken. 
3.  If  the  competent  authority  is  not  satisfied  with  the 
conditions  of.the-proposed release,  it may  ask  the notifier 
to  modify  such  ..  condit'ions  of  the release so as  to bring it 
into compliance with Article  3  of_ this Directive. 
4.  The  notifier may  proceed with  the release only when  he  has 
received  the  endorsement  of  the  competent  authority, 
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5.  The  Member  States  may  provide  for  derogations  from  the 
provisions  under articles  4  and  5.1  to  5.4  and  6  for 
deliberate releases  carried  out  by  or  under  the 
responsibility  of  a  public authority-which is designated as 
a  competent authority according  to  articles  3.2.  This 
derogation  does  not  affect the  obligation to  assess  the 
risk  posed  by  the release  concerned nor the obligation to 
submit  information to the  Commission  as  required in Article 
7 0 
ARTICLE  6 
On  the  completion  of  a  release the notifier shall  send to the 
competent  authority an  assessment of  the result of  the release 
in  respect of  any  risk  to  man  or  the  environment,  with 
particular reference to any product that he  intends  to notify. 
ARTICLE  7 
1.  The  Commission  shall  set up  a  system  of  exchange  of  the 
information  contained in  the notifications.  The  competent 
authorities  shall send  to the Commission  a  summary of  each 
notification received within  15  days  of its receipt. 
2.  The  Commission  shall  forward  these  summaries  to the other 
Member  States. 
3.  If  a  competent authority wants  more  information relative to 
releases  carried out in other Member  States, it may  ask the 
competent  authority of  this Member  State to  provide  them 
with  further  information. 
4.  The  competent authority  of  the  other  Member  States  may 
suggest  to  the  competent  authority  which  received  the 
original  notification any  modifications  to  the conditions 
of  the release. 
PART  C:  PLACING  ON  THE  MARKET  OF 
GENETICALLY  MODIFIED  ORGANISMS 
ARTICLE  8 
PRODUCTS 
Articles  9  to  16  of this Directive,  do  not apply to: 
medicinal products, 
- veterinary products, 
- foodstuffs,  feedingstuffs  and  their additives, 
CONTAINING - 8  -
- plants  and  animals  produced  or  used  in  agriculture, 
horticulture,  forestry,  husbandry  and  .  fisheries,  the 
reproductive  material thereof  and  the  products  containing 
these organisms, 
- or  to any  products  covered  by Community. 
includes  a  specific risk assessment. 
legislation which 
ARTICLE  9 
1.  Before  a  GMO  or a  combination of  GMOs  are  placed  on  the 
market  as  or in a  product,  the manufacturer or the importer 
to  the  Community  shall  submit  a  notification  to  the 
competent  authority of  the Member  State where  they are to 
be  placed  on  the  market  for  the  first  time.  This· 
notification shall contain: 
the  information  required  in  Annex  II,  extended  as 
necessary  to take  into account the diversity of sites of 
use  of  the  product,  and  an assessment  of  any risks  for 
man  and/or  the  environment  related  to  the  GMO(s) 
contained in the product, 
- the  conditions  for  the placing  on  the  market  of  the 
product,  including  specific  conditions  of  use  and· 
handling  and  a  proposal  for  labelling and  packaging which 
should  comprise at  least the  requirements  laid  down  in 
Annex  III. 
If,  on:the  basis  of  the results of  any release notified under 
Part  B  of  this  Directive,  or  on  substantive,  reasoned 
scientific  grounds,  a  notifier considers  that the placing on 
the  market  and  use of  a  product  do  not pose  any risk to man 
and/or  the  environment,  he  may  propose  not to  comply with  one 
or more  of  the  requirements  of  Annex  III.B. 
2.  Subject  to  the  agreement of  the  competent  authority,  the 
notifi~r  may  refer  in  this  notification  to  data  or 
experiences  from  releases  of  the  same  GMO(s)  previously 
notified at the  research and  development  level. 
3.  The  notifier 
notifications 
provided  that 
writing. 
may  also  refer  to 
previously  submitted 
the  latter have  given 
data  or  results  from 
by  other  notifiers, 
their  agreement  in 
4.  Each  new  product  which,  containing  or consisting  of  the 
same  GMO  or  combination  of  GMOs,  is  intended  for  a 





- 9  -
5.  If  new  information  has .become available with regard to the 
risks  of  the  product to  people or the environment,  either 
before or after the  endorsement,  the notifier shall: 
- revise the measures  specified in Article 9.1,  and 
inform the  competent authority immediately. 
ARTICLE  10 
1.  On  receipt of  the notification  referred to  in Article  9, 
the  competent authority  shall examine  it  for  compliance 
with  this Directive,  giving particular  attention  to  the 
risk  assessment  and  the  recommended  precautions  related to 
the safe use of  the product. 
2.  The  competent authority may  ask the notifier for additional 
information  or  suggest  further  tests  to  carry  out  or 
changes  in the conditions of placing on  the market  so as  to 
bring these  conditions  into compliance with the Directive. 
3.  When  the  competent  authority is satisfied that the placing 
on  the market of  the product  under the conditions specified 
in  the notification  is in  compliance with this Directive, 
it  shall  send  to· the  Commission  a  dossier  including  a 
summary  of  the  notification together  with  a  · statement of 
the  conditions  under  which  it  proposes  to  endorse  the 
placing on  the market  of the product. 
4.  The  competent authority  shall respond  to the notification 
within  90  days  of  receipt,  either by  indicating the  need 
for  further  information  and  evaluation,  or  measures  to 
bring  it into compliance with this Directive,  or forwarding 
the dossier referred to in Article 10.3 to the  Commission. 
ARTICLE  11 
1.  On  receipt of  the dossier  referred to  in Article 10,  the 
Commission  shall  forward  to all Member  States: 
- the  summary  of  the dossier, 
- any  other  information  it has  collected pursuant  to this 
Directive. - 10  -
2.  For  a  period  of three  months  after  the  Commission 
circulated  the  dossier  with  the  summary  of 
notification  and the proposed  conditions  for placing on 
market,  other competent  authorities  may  request 
competent  authority which  proposes  the  endorsement 
provide  further information  or change  the conditions 









3.  If  the competent  authority which  proposed the endorsement 
fails  to  comply  with the  requests  of  other  authorities 
regarding  further  information,  the risk assessement or the 
conditions  of  placing  on  the  market,  it  shall  give  its 
reasons  to the  competent authority concerned. 
4.  Should  it not  be possible  for the  competent  authorities 
concerned  to reach  an  agreement,  and  should any competent 
authority  feel,  on  the basis  of scientific evidence,  that 
the  placing on  the market of  the product may  pose risks to 
people  or the  environment,  within  this  period  of  three 
months,  the Commission  shall take  a  decision in accordance 
with  the procedure  laid down  in Article  20. 
5.  When  the  competent  authority that  received  the  original 
notification  has  provided  satisfactory  response  to  the 
requests  of  the  other  competent  authorities,  or  if  no 
suggestions  have  been  made  within  the  60-day  period,  or 
when  the  Commission  has  taken  a  favourable decision. in the 
case of  Art.  11.4,  it shall  endorse the  notification  so 
that the product may  be  placed  on  the market. 
6.  Once  a  product  has  been  endorsed,  it 
further  notification  throughout · the 
insofar  as  the  specific  conditions 
environments  and/or geographical  areas 
conditions  are strictly adhered  to. 
may  be  used.without 
European  Community 
of  use  and  the 
stipulated in these 
7.  Member  States shall  adopt all necessary measures  to ensure 
that  qsers  comply  with  the  conditions  of  use  specified in 
the  endorsement. 
ARTICLE  12 
Member  States shall take all necessary measures  to ensure that 
products  containing or  consisting of  GMOs  will  be  placed on 
the  market after  endorsement  only  if  their  labelling  and 
packaging is that endorsed  under Article  11. - 11  -
ARTICLE  13 
The  Member  States  may  not,  on  grounds  relating  to  the 
notificaiton  and  endorsement  of  a  deliberate  release  under 
this  directive,  prohibit,  restrict or  impede  the  placing  on 
the  market  of  products  containing or consisting of  GMOs  which 
comply with the  requirements  of this Directive. 
ARTICL.E...J.A 
1.  Where  a  Member  State has  evidence that  a  product which  has 
been  properly notified  and  endorsed  under this  Directive 
constitues  a  serious  risk to people or the environment,  it 
may  provisionally restrict  or prohibit  the use or sale of 
that  product  on  its territory.  It shall irnnediately inform 
the  Commission  and  the other  Member  States of  such action 
and  give  reasons  for its decision. 
2.  The  Commission  shall  take  a  decision on  the matter,  within 
3  months  following  the procedure  laid down  in Article  20. 
'l'he  Commission  shall publish in the Official Journal  a  list of 
all  the  products  receiving  final  endorsement  under  this 
Directive.  For  each  product,  the  GMO(s)  contained therein  and 
the use(s)  shall  be  clearly specified. 
)\RTICI.E  16 
1.  Member  States  shall  send  to  the  Commission,  at the  end  of 
each  year,  a  brief  factual  report  on  the control  of  the  use 
of all products  placed  on  the market  under  this  Directive. 
2.  'L'hc  Conunist>ion  shall  send  to  the  Europc~an Parliament,  every 
three  years,  a  report  on  the control  by the  Member  States 
of  the products  placed  on  the market  under this  Directive. 
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PART  D:  FINAL  PROVISIONS 
ARTICLE_ll 
1.  The  notifier  may  indicate 
notifications  submitted under 
Directive,  the  disclosure 
competitive  position,  that 
Verifi~ble justification must 
the  information  in  the 
this Articles  4  and  9  of  this 
of  which  might  harm  his 
should  be  kept  secret. 
be  given  in  such  cases. 
2.  ~he  competent  authority  shall  decide  on  its 
responsibility which  information will be kept  secret. 
own 
3.  In  no  case may  the following_.information  be  kept  secret: 
. ...... _.: 
-identity  of  the  GMO<s>,  name  and_ address  of  the notifier, 
purpose  of  the  release or  of  the  product,  and  site of 
release,  or areas  of  use. 
;'.~' 
.~  .. - th~  evaluatio~ o~  ·fQ~e~~e~tii~~ffects, in particular any 
..  :'•  pathogenic  and· ecologically. ·disruptive effects. 
•  •  .•  •  q,  . 
•  .  ·.  •  't"  '''\.>  ·~  •  ........  ';'.  ~- ~· -i"~"'  .. 
.  , . -.for  experimental  :  r~leases:  ·::  .  methods  and  plans  for 
·  ·.  ·.monitoring.·· th,e'GMO(s.),._for·decontaminating  the area<s>  of 
· release,  and. for· emer·g·ency  response. 
.  ·.  .  •  ~  ;\.  .·;.·  ,  ,:  ~-a·;"'  .  ·,, ..  ~.,. 
.> 
- for  placing  qh  the marketi:: methods 
~-:GMO(s)  cont~ined  in  the  ·product 
· response  in  cc:t"se  of· misuse . 
.  ·'  ·!·;.tt~-: .' 
for 
and 
monitoring  the 
for  emergency 
4.  Confidential  information  br~ught to the attention either of 
the  Commission· o:t  of .a· "'·c;:ompetent  authority  shall be  kept 
·.  _._·. · 'secret.  .,  ,  ._. 
",':... 
..  .·· .. 
·!  According  to  the 
::::,f;;·:  ·.'·Commission  shall 
_procedure 
adapt  ·the 
by: 
la·i.~  down  in 
annexes  of 
Article  20, 
this  Directive 
the 
to 
._,:~  ... {.'  technical··  pro~.~~.ss 
\~.:':'·..  _:  by  am~~ding' new 
.'  ·.  appropriate 
:  . 
techniques  to 
;. 
be  covered  or  deleting  as 
_.  ~-·.·· ..  ~  . . '•  .;, ··~ 
th:~  notification requirements  set out  in Annexes  II 
to  t.ake  into  account  the  potential  hazard  of  the 
.''  .,. 
·-·  ...  -~ ' ..  ~ .  .  ~ 
.  ~. ,,  .....  .._  .· 
·.  ;-·------
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ARTICLE  19 
1.  The  Commission shall  be  assited 
advisory  nature  composed  of  the 
Member  States and  chaired by  the 
Commission. 









2.  The  Commission  shall  function  in  accordance  with  the 
procedures  laid down  in Article  20. 
ARTICLE  20 
1.  Where  the procedure  laid down  in this Article is  followed, 
representative  of  the  Commission  shall  submit  to  the 
Committee  a  draft  of  the  measures  to  be  taken.  The 
Committee  shall deliver  its opinion on  the draft,  within  a 
time  limit which  the  chairman may  lay down  according to the 
urgency  of  the  matter,  if necessary by taking  a  vote.  The 
opinion  shall be  recorded in the minutes;  in addition,  each 
Member  State have  the  right  to have its position recorded 
in  the minutes.  The  Commission  shall  take  the  utmost 
account  of  the  opinion delivered  by  the  Committee.  It 
shall  inform the  Committee  of  the  manner  in  which  its 
opinion has  been  taken into account. 
ARTICLE  21 
1.  Member  States and  the Commission  shall meet  regularly and 
exchange  information on  the experience acquired with regard 
to  the prevention  of  risks  related to the release of  GMOs 
to the environment. 
2.  Every  three years,  Member  States shall send the  Commission 
a  report  on  the measures  taken to  implement the provisions 
of  this  Directive,  the  first time  being  on  1st September 
1991. 
3.  Every  three years,  the  Commission  shall publish a  summary 
based  on  the  reports  referred to in paragraph  2,  the first 
time  being  in  1992. 
ARTICLE  22 
1.  Member  States shall  bring  into  force  the  laws,  regulations 
and  administrative provisions  necessary to  comply with this 
Directive  within  a  period  of  18  months  from  its 
notification. 
2.  The  Member  States  shall immediately  inform the Commission 
of  all  laws  regulations  and  administrative  provisions 
adopted  in  implementation of  this  Directive. - 14  -
ARTICLE  23 
This  Directive is addressed to the Member  States. 
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2  ·') : :  16  . ANNEX  I 
Genetically  modified  organisms  are organisms 
obtained  by  such  techniques  as  recombinant 
injection,  macroinjection microencapsulation, 
organel transplantation or genetic manipulation 
which  can  be 
DNA,  micro-
nuclear  and 
of viruses. 
."{. ANNEX  II 
The  notifications  for  a  del~berate  ~elease  referred  to  in 
Article  4  and  for  placing  on  the  market  referred  to  in 
Article  9  must  provide the  information set out below. 
Not all the points  included will apply to every case.  It is to 
be  expected,  therefore,  that  individual  notifications  will 
address  only  the  particular  subset  of  issues  that  are 
appropriate to  individual situations.  In· each  case  where it 
is not  technically possible or it does  not  appear necessary to 
give the  information,  the reasons  shall be  stated. 
The  level  of detail  required in  response  to  each  subset  of 
considerations is  also likely  to vary according to the nature 
and  the  scale of  the proposed  release. 
The  description  of  the  methods  used  or  the  reference  to 
.  standardized or  internationally recognized  methods  shall also· 
be  mentioned  in the dossier,  together with the  name  of  the  body 
or bodies  responsible  for  carrying out the studies. 
1 
. l  . . 
·.l 
! 
.i  ~ ~-
1.  IDENT.IFICA'i'ION  AND  CHARACTERISTICS  OF  THE  ORGANISM 
a)  Information relating to the parental organisms 
Scientific name 
Taxonomy 
Other  names  (usual  name,  strain  name,  cultivar 
name,  etc.). 
Phenotypic  and genetic markers. 
b>  Information relating to the recipient organism 
Description 
techniques 
of  identification  arid  detection 
Sensitivity,· reliability  (in quantitative  terms>  and_ 




oii.  natural 
competitors  and 
the geographic distribution and  of  the 
of the organism including information 
predators,  preys,  parasites  and 
symbionts 
Potential  for  genetic  transfer  and  exchange  with 
other organism 
Verification  of  the  genetic  stability 
organisms  and  factors  affecting it 
of  the 
Pathological,  ecological  and  phy~iological  traits of 
the organism: 
* Classification  according  to  existing 
rules 
Cornm1,1nity 
*  Generation time  in natural  ecosystems,  sexual  and 
asexual  reproductive  cycle 
*  Information  on  surviv~l,  including seasonality and 
the  ability  to  fo~m  survival  structures  e·.g.: 
seeds,  spo~es or sclerotia 
*  Pathogenicity:  infectivity,  toxigenicity, 
virulence,  allergenicity,  carrier  (vector)  of 
pathogenj  possible  vectors,  host  range  including 
non-target·  organisms.  Possible  activation  of 
latent viruses  <proviruses).  Ability to colonize 
other  organisms  · *  Antibiotic resistance,  and potential  use of  these 
antibiotics in  humans  and  domestic  organisms  for 
prophylaxis  and  therapy 
*  Involvement  in  environmental  processes:  primary 
production,  nutrient  turn-over,  decomposition  of 
organic matter,  respiration,  etc .. 
c)  Information relating to the genetic modification 
Methods  used  for the modification 
Methods  used  to construct and  introduce the insert(s) 
into the recipient 
Purity of  the insert from  any  unknown  sequence 
Functional  identity  and  location  of  the  altered 
inserted nucleic acid segment(s)  in question 
.  - Description of  any new genetic trait(s)  or phenotypic 
characteristics which  may  be  expressed or  no  longer 
expressed 
History of  previous  genetic  manipulations  with  the 
parental  organisms. 
2.  OTHER  INFORMATION  NECESSARY  FOR  RISK  EVALUATION 
a)  Character~stics  of  the  genetically  modified  organism 
(GMO>  affecting survival,  multiplication··and dispersion 
Biological  features  which  affect  survival, 
multiplication and dispersion 
Behaviour in  simulated natural  environments,  such  as 
microcosms,  growth  rooms,  greenhouses,  etc. 
Known  or  predicted environmental  conditions which  may 
affect  survival,  multiplication  and  dissemination 
<wind,  water,  soil, etc.) 
Sensitivity to specific agents 
b>  Interactions of  the  GMO  with the biological  systems: 
Predicted habitat of  the  GMO 
Genetic  transfer capability 
Likelihood  of  post-release  selection  of  genetic 
transfer leading  to  the  expression  of  undesirable 
effects  in  the organisms  released or/and in any other 
organism in the environment 
Measures  employed  to  ensure  genetic 
Description of  genetic traits  which  may 
minimise  dispersal  of  genetic material 
stability. 
prevent  or 
··' 
\-' 
..  ' 
. ~ .  j. 
Routes  of  biological dispersal,  known  or  potential 
modes  of  interaction with  the  disseminating  agent, 
including  inhalation,  ingestion,  surface  contact, 
burrowing,  etc  . 
Potential for  excessive population  increase  in  the 
environment 
.Identification and description of the target organism 
Anticipated  mechanism  and  result  of  interaction 
between  the released GMO(s)  and  the target  organism 
Identification  and·  description  of  non-target 
organisms  which  may  be  affected unwittingly 
Known  or  predicted effects on 
the  environment  impact  on 
competitors,  preys,  hosts, 
non-target organisms  in 
population  levels  of 
symbionts,  predators, 
parasites  and  pathogens  · 
Other potentially significant interactions with  the 
environment. 
3.  GEOGRAPHICAL  LOCATION  OF  THE  SITE  OF  RELEASE  (in the case of 
notifications  for  placing on  the market,  the  site(s)  of 
release will  be  the intended areas  of  use of  the product) 
a)  Geographical  location of  the site(s),  including: 
Physical or biological proximity to  humans 
Size of  local population . 
. Economic  activities  of  local  populations  which  are 
based  on  the natural resources of the area 
b)  Description  of  the site,  including: 
Climatic characteristics 
Geographical,  geological 
teristics 
and  pedological  charac-
Flora  and  fauna,  including  crops,  livestock  and 
migratory species 
Surrounding  ecosystems  to.which  the  organism  could 
spread 
c)  A  comparison  of  the  natural habitat  of  the  recipient 
organism with the  proposed site(s)  of  release. 
4 .  CQNDl'J2.I..Q1Ls___o_r::_'].'l!.f~2EL.IliERATJUlElzJ:dl.S.I=~  < on  1 y  for  not if  i cat: ions 





the  ·proposed 
program  and 
deliberate  release, 
the'  purpose<s>  or 
b)  Preparation of  the site previous  to the release 
c>  Size of  the site 
d>  Method,  amount,  frequency  and duration of  t~~ release 
e)  Methods  of  human  intervention 
methods,  etc .. )  on  the site. 
(mining,  cultivation  , 
-~ 
f>  Worker  safety measures  during  the release 
g>  Post-release treatment of  the site 
5.  CONTROL  AND  EMERGENCY  RESPONSE  PLANS 
a)  Monitoring  techniques 
Methods  for  tracing the  GMO<s>,  and  for  monitoring  ; 
its effects 
Detection  and  identification  techniques  to 








identify  the 
from  the 
reliability  of 
GMO<s>,  and  to 
parental  ones>, 
the  monitoring 
Techniques  for  detecting  transfer  of  the  donated 
genetic material  to other organisms 
For  experimental  releases,  duration  and  frequency  of 
the monitoring 
b>  Response  plans  in case  of  an  unexpected  spread  of  the 
organism 
Methods  and  procedures  for  controlling  the  GMO<s> 
in case  of  unexpected  spread 
Methods  for  decontamination of  the  areas  affected, 
e.g.  eradiction of  the  GMO(s) 
Methods  for  disposal  or 
animals,  soils,  etc ..  that 
after t.he  spread 
sanitation  of 
were  exposed 
plants, 
during  or 
Methods  for  the isolation of  the area affected by  the 
spread 
Plans  for  protecting human  and  environmental  health 
in case  of  the  occurrence  of  an  undesirable effect 
S4 c)  ~ontrol of  the release  <only in  case of  notifications 
under Article  4> 
Methods  and  procedures: to  minimize  the  spread of  the 
GMO(s)  beyond  the site of  release 
Methods  and  procedures  to  protect  the  site  from 
intrusion by unauthorized individuals. 
~ ..  ····.·.• 
... 
.:· 
.Cf A.  The  following  information 
notification for  placing on 
addition to that of  Annex  II: 
shall  be 
the  market 
ANNEX  III 
provided  in 
of  products, 
the 
in 
1.  Name  of  the product  and  name(s)  of  GMO(s)  contained 
there in 
2.  Name  of  the man  2.  Name  of  the manufacturer  or di 
address  in the  Community 
3.  Specificity of  the  product,  exact  conditions  of  use 
including,  when  appropriate,  the  type  of  environment 
and/or the  geographical area(s)  of  the  Community  for 
which  the product is suited 
4.  Type  of  expected use:  industry,  agriculture and  skilled 
trades,  consumer use  by public at large. 
B.  The  following  information shall be  provided,  when  relevant, 
in addition  to that  of  Annex  III.A,  in  accordance  with 
Article  9. 
1.  Measures  to  take  in  case  of  unintended  release  or 
misuse. 
2.  Specific instructions  or recommendations  for  storage  and 
handling 
3.  Estimated production and/or  imports  to the  Community 
4.  Proposed packaging.  This  must  be  appropriate  so  as  to 
avoid  unintended  release of  the  GMO(s)  during  storage, 
or  ~t a  later stage 
5.  Proposed  labelling.  This  must  include,  at 
summarized  form,  the  information  referred to 
A.l,  A.2,  A.3,  B.l  and  B.2 .of  this Annex. 
least  in 
in points 
'  I 















DRAFT  COUNCIL  DIRECTIVE  ON  THE  DELIBERATE  RELEASE 
TO  THE  ENVIRONMENT  OF  GENETICALLY  MODIFIED  ORGANISMS. 
COMPETITIVENESS  AND  EMPLOYMENT  IMPACT  ASSESSMENT 
II. 
WHAT  IS  THE  MAIN  REASON  FOR  INTRODUCING  THE  MEASURE 
To  approximate  the Member  States'  laws  and  administrative 
provisions  regarding  the  deliberate  release  to  the 
environment of  genetically modified  organisms  <GMOs>  to 
the environment,  and  to  ensure that  these releases,  for 
experimental  and  commercial  purposes,  will  take  place 
under  conditions  of  human  and  environmental safety which 
are as  high as  reasonably practicable.  These  releases 
will involve,  for  example,  microorganisms  to  be  used as 
pesticides,  toxic  chemical  degraders,  etc,  as  well  as 
plants  or  animals  adapted  to  adverse  environmental 
conditions,  or  resistant to  diseases.  As  some  Member 
States are  introducing regulations  on  this  matter,  the 
elaboration of  a  Community directive is essential to avoid 
fragmentation  of  the market. 
FEATURES  OF  THE  BUSINESSES  IN  QUESTION 
This  a  high-technology field,  in which  most  activities are 
developped  by  large  chemical  manufacturers,  and  by 
research  institutions  very often supported by these  large 
industries.  The  number  of  PMEs  is small at this moment, 
and  they  are  located  in  well-developped  areas,  not 
eligible for  regional  aid  or the  ERDF.  However,  the 
number  of  PMEs  is potentially high in the  future,  as  this 
currently expensive  technology becomes  more  affordable. 
Many  of  the applications  envisaged are products  taylored 
for very  specific uses:  the sort of  products  appropriate 
for  SMEs. 
III.  WHAT  DIRECT  OBLIGATIONS  DOES  THIS  MEASURE  IMPOSE  ON 
BUSINESS? 
The  directive  requires  the  researcher  and/or  the 
manufacturer  to  take  measures  to  ensure  human  and 
environmental  safety,  and  to  submit  a  notification to a 
national  competent  authority.  The  notification  will  be 
submitted  in  all  cases  of  releases  of  GMOs,  as  the little 
knowledge  and  experience on  possible risks  do  not  allow, 
at this  moment,  the  exemption  of  certain categories  of 
organisms.  This  notification,  however  extensive,  should 
not  require  burdensome  additional  work:  it  should 
essentially consist  of  the  information already available 
for  the  business  in  order to  ensure  the  safety of  the 
release.  These  notificatons  will  not  be  required  of  the 
final  users  of  the  product,  i.e.  farmers,  environmental 
clean-up  companies,  etc. 
St •  ,!• 
- 2  -
IV.  WHAT  INDIRECT  OBLIGATIONS  ARE  LOCAL  AUTHORITIES  LIKELY  TO 
IMPOSE  ON  BUSINESSES? 
To  keep  a  high  level of public  information. 
v.  ARE  THERE  ANY  SPECIAL.MEASURES  IN  RESPECT  OF  SMEs? 
No. 
VI.  WHAT  IS  THE  LIKELY  EFFECT  ON: 
<a>  the  competitiveness of businesses, 
<b>  employment? 
<a>  The  harmonization  of  procedures  at  .Community  level 
should have  a  positive  effect on  the competitiveness 
of  SMEs.  On  the other hand,  the necessary adoption of. 
safety measures  <i.e.,fencing of  the areas of release, 
further testing  and  the  like>  in  order to  make  the· 
releases as  safe as  possible may,  in  some  occasions, 
be  rather  expensive.  These  costs  could  be, 
proportionally,  more  burdensome  for  SMEs. 
<b>  None. 
VII.  HAVE  BOTH  SIDES  OF  INDUSTRY  BEEN  CONSULTED? 
This  proposal  has  been  discussed  with  the  European 
Biotechnology  Coordination  group,  composed  of 
representa.tives  ·.from  different  European  Industry's 
organisations:  AMFEP,  CEFIC,  CIAA,  EFPIA,  GIFAP..  The 
ernployee's.side,  however,·has  not  been consulted. 
Industry's view  is that  Community-wide  harmonization  of 
procedures  is  badly  needed,  but  it  expressed  its 
reservation to  an  endorsement  by regulatory bodies  prior 
to the  releases. 
·.·.:,_. 
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